Differential	O
requirement	O
for	O
the	O
transcription	B-protein
factor	I-protein
PU.1	I-protein
in	O
the	O
generation	O
of	O
natural	B-cell_type
killer	I-cell_type
cells	I-cell_type
versus	O
B	B-cell_type
and	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

PU.1	B-protein
is	O
a	O
member	O
of	O
the	O
Ets	B-protein
family	I-protein
of	I-protein
transcription	I-protein
factors	I-protein
required	O
for	O
the	O
development	O
of	O
various	O
lymphoid	B-cell_line
and	I-cell_line
myeloid	I-cell_line
cell	I-cell_line
lineages	I-cell_line
,	O
but	O
its	O
role	O
in	O
natural	B-cell_type
killer	I-cell_type
(	I-cell_type
NK	I-cell_type
)	I-cell_type
cell	I-cell_type
development	O
is	O
not	O
known	O
.	O

The	O
study	O
shows	O
that	O
PU.1	B-protein
is	O
expressed	O
in	O
NK	B-cell_type
cells	I-cell_type
and	O
that	O
,	O
on	O
cell	O
transfer	O
into	O
alymphoid	O
Rag2/gammac	O
(	O
-/-	O
)	O
mice	O
,	O
hematopoietic	B-cell_type
progenitors	I-cell_type
of	O
PU.1	B-cell_type
(	I-cell_type
-/-	I-cell_type
)	I-cell_type
fetal	I-cell_type
liver	I-cell_type
cells	I-cell_type
could	O
generate	O
functional	O
NK	B-cell_type
cells	I-cell_type
but	O
not	O
B	B-cell_type
or	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Nevertheless	O
,	O
the	O
numbers	O
of	O
bone	B-cell_type
marrow	I-cell_type
NK	I-cell_type
cell	I-cell_type
precursors	I-cell_type
and	O
splenic	B-cell_type
mature	I-cell_type
NK	I-cell_type
cells	I-cell_type
were	O
reduced	O
compared	O
to	O
controls	O
.	O

Moreover	O
,	O
PU.1	B-cell_type
(	I-cell_type
-/-	I-cell_type
)	I-cell_type
NK	I-cell_type
cells	I-cell_type
displayed	O
reduced	O
expression	O
of	O
the	O
receptors	O
for	O
stem	B-protein
cell	I-protein
factor	I-protein
and	O
interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-7	I-protein
,	O
suggesting	O
a	O
nonredundant	O
role	O
for	O
PU.1	B-protein
in	O
regulating	O
the	O
expression	O
of	O
these	O
cytokine	B-DNA
receptor	I-DNA
genes	I-DNA
during	O
NK	O
cell	O
development	O
.	O

PU.1	B-cell_type
(	I-cell_type
-/-	I-cell_type
)	I-cell_type
NK	I-cell_type
cells	I-cell_type
also	O
showed	O
defective	O
expression	O
of	O
inhibitory	O
and	O
activating	O
members	O
of	O
the	O
Ly49	B-protein
family	I-protein
and	O
failed	O
to	O
proliferate	O
in	O
response	O
to	O
IL-2	B-protein
and	O
IL-12	B-protein
.	O

Thus	O
,	O
despite	O
the	O
less	O
stringent	O
requirement	O
for	O
PU.1	B-protein
in	O
NK	O
cell	O
development	O
compared	O
to	O
B	B-cell_type
and	I-cell_type
T	I-cell_type
cells	I-cell_type
,	O
PU.1	B-protein
regulates	O
NK	O
cell	O
differentiation	O
and	O
homeostasis	O
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

HEMATOPOIESIS	NULL
Differential	NULL
requirement	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
versus	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
Francesco	NULL
Colucci	NULL
,	NULL
Sandrine	NULL
I.	NULL
Samson	NULL
,	NULL
Rodney	NULL
P.	NULL
DeKoter	NULL
,	NULL
Olivier	NULL
Lantz	NULL
,	NULL
Harinder	NULL
Singh	NULL
,	NULL
and	NULL
James	NULL
P.	NULL
Di	NULL
Santo	NULL
PU.1	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
various	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cell	NULL
lineages	NULL
,	NULL
but	NULL
its	NULL
role	NULL
in	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cell	NULL
development	NULL
is	NULL
not	NULL
known	NULL
.	NULL

The	NULL
study	NULL
shows	NULL
that	NULL
PU.1	NULL
is	NULL
expressed	NULL
in	NULL
NK	NULL
cells	NULL
and	NULL
that	NULL
,	NULL
on	NULL
cell	NULL
transfer	NULL
into	NULL
alymphoid	NULL
/-mice	NULL
,	NULL
hematopoietic	NULL
progenitors	NULL
of	NULL
PU.1-	NULL
``	NULL
-fetal	NULL
liver	NULL
cells	NULL
could	NULL
generate	NULL
functional	NULL
NK	NULL
cells	NULL
but	NULL
not	NULL
B	NULL
or	NULL
T	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
numbers	NULL
of	NULL
bone	NULL
marrow	NULL
NK	NULL
cell	NULL
precursors	NULL
and	NULL
splenic	NULL
mature	NULL
NK	NULL
cells	NULL
were	NULL
reduced	NULL
compared	NULL
to	NULL
controls	NULL
.	NULL

Moreover	NULL
,	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
displayed	NULL
reduced	NULL
expression	NULL
of	NULL
the	NULL
receptors	NULL
for	NULL
stem	NULL
cell	NULL
factor	NULL
and	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-7	NULL
,	NULL
suggesting	NULL
a	NULL
nonredun-dant	NULL
role	NULL
for	NULL
PU.1	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
cytokine	NULL
receptor	NULL
genes	NULL
during	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL

PU.1-	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
also	NULL
showed	NULL
defective	NULL
expression	NULL
of	NULL
inhibi-	NULL
tory	NULL
and	NULL
activating	NULL
members	NULL
of	NULL
the	NULL
Ly49	NULL
family	NULL
and	NULL
failed	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
and	NULL
IL-12	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
the	NULL
less	NULL
stringent	NULL
requirement	NULL
for	NULL
PU.1	NULL
in	NULL
NK	NULL
cell	NULL
development	NULL
compared	NULL
to	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
PU.1	NULL
regulates	NULL
NK	NULL
cell	NULL
differentiation	NULL
and	NULL
homeostasis	NULL
.	NULL

(	NULL
Blood	NULL
.	NULL

2001	NULL
;	NULL
97:2625-2632	NULL
)	NULL
©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
Introduction	NULL
Natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
are	NULL
a	NULL
distinct	NULL
subset	NULL
of	NULL
lymphocytes	NULL
that	NULL
mediate	NULL
important	NULL
functions	NULL
in	NULL
innate	NULL
immunity	NULL
being	NULL
able	NULL
to	NULL
eliminate	NULL
tumor	NULL
cells	NULL
and	NULL
to	NULL
produce	NULL
cytokines	NULL
without	NULL
prior	NULL
sensitization	NULL
(	NULL
reviewed	NULL
in	NULL
Trinchieri	NULL
'	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
can	NULL
distinguish	NULL
cells	NULL
with	NULL
disparate	NULL
levels	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
I	NULL
expression	NULL
,	NULL
killing	NULL
cells	NULL
that	NULL
,	NULL
due	NULL
to	NULL
viral	NULL
infections	NULL
or	NULL
transformation	NULL
,	NULL
have	NULL
low	NULL
MHC	NULL
expression	NULL
,	NULL
and	NULL
sparing	NULL
those	NULL
with	NULL
normal	NULL
expression	NULL
(	NULL
reviewed	NULL
in	NULL
Ljunggren	NULL
and	NULL
Karre	NULL
?	NULL
)	NULL

.	NULL

Such	NULL
discrimination	NULL
is	NULL
mediated	NULL
by	NULL
self	NULL
MHC-specific	NULL
inhibitory	NULL
receptors	NULL
on	NULL
NK	NULL
cells	NULL
that	NULL
belong	NULL
to	NULL
one	NULL
of	NULL
3	NULL
groups	NULL
:	NULL
killer	NULL
immunoglobu-lin-like	NULL
receptors	NULL
on	NULL
human	NULL
NK	NULL
cells	NULL
,	NULL
lectin-like	NULL
Ly49	NULL
receptors	NULL
on	NULL
murine	NULL
NK	NULL
cells	NULL
,	NULL
and	NULL
lectin-like	NULL
NKG2/CD94	NULL
cells	NULL
that	NULL
are	NULL
found	NULL
on	NULL
both	NULL
human	NULL
and	NULL
rodent	NULL
NK	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
Lanier	NULL
``	NULL
)	NULL
.	NULL

Despite	NULL
our	NULL
appreciation	NULL
of	NULL
these	NULL
different	NULL
NK	NULL
cell	NULL
functions	NULL
,	NULL
the	NULL
developmental	NULL
relationship	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
other	NULL
hematopoietic	NULL
lineages	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

A	NULL
rare	NULL
population	NULL
of	NULL
common	NULL
lymphoid	NULL
progenitors	NULL
(	NULL
CLPs	NULL
)	NULL
that	NULL
can	NULL
give	NULL
rise	NULL
to	NULL
T	NULL
,	NULL
B	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
mouse	NULL
bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
,	NULL
and	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
derive	NULL
from	NULL
a	NULL
common	NULL
progenitor	NULL
during	NULL
fetal	NULL
life	NULL
.	NULL
``	NULL

''	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
also	NULL
share	NULL
expression	NULL
of	NULL
several	NULL
differentiation	NULL
antigens	NULL
and	NULL
effector	NULL
functions	NULL
,	NULL
yet	NULL
the	NULL
great	NULL
majority	NULL
of	NULL
T	NULL
cells	NULL
are	NULL
generated	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
whereas	NULL
the	NULL
predominant	NULL
site	NULL
for	NULL
NK	NULL
cell	NULL
development	NULL
is	NULL
the	NULL
BM	NULL
.	NULL

Part	NULL
of	NULL
the	NULL
difficulty	NULL
in	NULL
understanding	NULL
the	NULL
developmental	NULL
relationship	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
other	NULL
hematopoietic	NULL
lineages	NULL
stems	NULL
from	NULL
our	NULL
incomplete	NULL
knowledge	NULL
of	NULL
NK	NULL
cell	NULL
ontogeny	NULL
.	NULL

Notwithstand-ing	NULL
,	NULL
it	NULL
is	NULL
now	NULL
clear	NULL
that	NULL
development	NULL
of	NULL
NK	NULL
cells	NULL
is	NULL
strictly	NULL
dependent	NULL
on	NULL
cytokines	NULL
that	NULL
promote	NULL
survival	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
.	NULL

Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-15	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
NK	NULL
cell	NULL
differentiation	NULL
,	NULL
thus	NULL
NK	NULL
cells	NULL
are	NULL
extremely	NULL
reduced	NULL
or	NULL
absent	NULL
in	NULL
mice	NULL
deficient	NULL
for	NULL
IL-15	NULL
``	NULL
or	NULL
for	NULL
any	NULL
of	NULL
the	NULL
IL-15	NULL
receptor	NULL
subunits	NULL
(	NULL
IL-15Ra,8	NULL
IL-2RB	NULL
,	NULL
°	NULL
or	NULL
its	NULL
downstream	NULL
signaling	NULL
molecules	NULL
Jak3*	NULL
and	NULL
Stat5	NULL
.	NULL
``	NULL

However	NULL
,	NULL
IL-15	NULL
intervenes	NULL
in	NULL
a	NULL
rather	NULL
late	NULL
stage	NULL
of	NULL
development	NULL
,	NULL
when	NULL
the	NULL
commitment	NULL
to	NULL
the	NULL
NK	NULL
cell	NULL
lineage	NULL
has	NULL
already	NULL
been	NULL
made	NULL
.	NULL

Although	NULL
``	NULL
early	NULL
acting	NULL
``	NULL
cytokines	NULL
,	NULL
including	NULL
IL-7	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
,	NULL
and	NULL
FIkK2L/FIt3L	NULL
,	NULL
are	NULL
best	NULL
candidates	NULL
for	NULL
driving	NULL
the	NULL
commitment	NULL
to	NULL
the	NULL
NK	NULL
cell	NULL
lineage	NULL
(	NULL
reviewed	NULL
in	NULL
Williams	NULL
et	NULL
al	NULL
``	NULL
``	NULL
)	NULL
,	NULL
the	NULL
relative	NULL
contribution	NULL
of	NULL
these	NULL
growth	NULL
factors	NULL
is	NULL
not	NULL
fully	NULL
appreciated	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
marking	NULL
NK	NULL
cell	NULL
specification	NULL
are	NULL
not	NULL
completely	NULL
understood	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
these	NULL
cytokines	NULL
activate	NULL
genetic	NULL
programs	NULL
that	NULL
use	NULL
multiple	NULL
transcription	NULL
factors	NULL
to	NULL
silence	NULL
or	NULL
to	NULL
activate	NULL
lineage-specific	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
although	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
lineage	NULL
commitment	NULL
during	NULL
lymphopoiesis	NULL
has	NULL
been	NULL
quite	NULL
extensively	NULL
studied	NULL
in	NULL
the	NULL
context	NULL
of	NULL
B-	NULL
and	NULL
T-cell	NULL
development	NULL
(	NULL
reviewed	NULL
in	NULL
Glimcher	NULL
and	NULL
Singh	NULL
``	NULL
)	NULL
,	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
control	NULL
engagement	NULL
to	NULL
the	NULL
NK	NULL
cell	NULL
lineage	NULL
have	NULL
only	NULL
recently	NULL
started	NULL
to	NULL
be	NULL
identified	NULL
.	NULL

Mice	NULL
deficient	NULL
for	NULL
interferon	NULL
regulatory	NULL
factor-1	NULL
fail	NULL
to	NULL
develop	NULL
NK	NULL
cells	NULL
,	NULL
due	NULL
to	NULL
impaired	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
115	NULL
locus	NULL
.	NULL
``	NULL

The	NULL
absence	NULL
of	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
y	NULL
(	NULL
CREB-y	NULL
)	NULL
impinges	NULL
selectively	NULL
on	NULL
NK	NULL
cell	NULL
development	NULL
and	NULL
not	NULL
on	NULL
B	NULL
or	NULL
T	NULL
lymphopoiesis	NULL
.	NULL
'	NULL

''	NULL
Disruption	NULL
of	NULL
the	NULL
1d2	NULL
gene	NULL
results	NULL
in	NULL
the	NULL
block	NULL
of	NULL
NK	NULL
cell	NULL
development	NULL
,	NULL
whereas	NULL
Band	NULL
T-cell	NULL
differentiation	NULL
unfolds	NULL
normally	NULL
.	NULL
'	NULL

''	NULL
The	NULL
further	NULL
understanding	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
NK	NULL
cells	NULL
may	NULL
help	NULL
to	NULL
define	NULL
stages	NULL
in	NULL
which	NULL
lineage	NULL
specification	NULL
takes	NULL
place	NULL
,	NULL
thereby	NULL
clarifying	NULL
the	NULL
developmental	NULL
relationship	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
B-	NULL
and	NULL
T-cell	NULL
lineages	NULL
.	NULL

From	NULL
the	NULL
Laboratory	NULL
for	NULL
Cytokines	NULL
and	NULL
Lymphoid	NULL
Development	NULL
,	NULL
Pasteur	NULL
Institute	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
Illinois	NULL
;	NULL
and	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
U25	NULL
,	NULL
Necker	NULL
Hospital	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
October	NULL
11	NULL
,	NULL
2000	NULL
;	NULL
accepted	NULL
January	NULL
11	NULL
,	NULL
2001	NULL
.	NULL

F.C	NULL
.	NULL

and	NULL
S.1.S	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
,	NULL
Fondation	NULL
pour	NULL
la	NULL
Recherche	NULL
Médicale	NULL
,	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
and	NULL
the	NULL
Pasteur	NULL
Institut	NULL
,	NULL
by	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
(	NULL
INSERM	NULL
)	NULL
BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
(	NULL
F.C	NULL
.	NULL
)	NULL

,	NULL
and	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Ministére	NULL
de	NULL
'Education	NULL
Nationale	NULL
de	NULL
la	NULL
Recherche	NULL
et	NULL
de	NULL
la	NULL
Technologie	NULL
(	NULL
S.1.S	NULL
.	NULL
)	NULL

.	NULL

Reprints	NULL
:	NULL
Francesco	NULL
Colucci	NULL
,	NULL
Laboratory	NULL
for	NULL
Cytokines	NULL
and	NULL
Lymphoid	NULL
Development	NULL
,	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Pasteur	NULL
Institute	NULL
,	NULL
25-28	NULL
,	NULL
rue	NULL
Dr	NULL
Roux	NULL
75015	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
e-mail	NULL
:	NULL
cecco	NULL
@	NULL
pasteur.fr	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

Therefore	NULL
,	NULL
and	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
,	NULL
this	NULL
article	NULL
is	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
.	NULL

©2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
2625	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2626	NULL
-	NULL
COLUCCl	NULL
etal	NULL
The	NULL
Ets	NULL
(	NULL
E26	NULL
transformation	NULL
specific	NULL
)	NULL
family	NULL
of	NULL
oncogenic	NULL
transcription	NULL
factors	NULL
comprises	NULL
more	NULL
than	NULL
20	NULL
members	NULL
that	NULL
are	NULL
conserved	NULL
throughout	NULL
evolution	NULL
,	NULL
regulating	NULL
cell	NULL
fate	NULL
of	NULL
multiple	NULL
cell	NULL
types	NULL
in	NULL
worms	NULL
,	NULL
flies	NULL
,	NULL
birds	NULL
,	NULL
and	NULL
mammals	NULL
(	NULL
reviewed	NULL
in	NULL
Bassuk	NULL
and	NULL
Leiden	NULL
'	NULL
``	NULL
)	NULL
.	NULL

Several	NULL
mammalian	NULL
Ets	NULL
transcription	NULL
factors	NULL
are	NULL
expressed	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

Gene-targeting	NULL
experiments	NULL
have	NULL
helped	NULL
to	NULL
define	NULL
the	NULL
role	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
in	NULL
mouse	NULL
hematopoietic	NULL
development	NULL
.	NULL

One	NULL
Ets	NULL
family	NULL
member	NULL
,	NULL
PU.1	NULL
(	NULL
purine	NULL
rich	NULL
box-1	NULL
)	NULL
or	NULL
Spi-1	NULL
(	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
integration	NULL
site-1	NULL
)	NULL
is	NULL
required	NULL
for	NULL
the	NULL
differentiation	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
.	NULL
'	NULL

''	NULL
``	NULL
Although	NULL
specification	NULL
of	NULL
erythrocytes	NULL
and	NULL
megakaryo-cytes	NULL
can	NULL
occur	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
,	NULL
monocytes	NULL
,	NULL
mature	NULL
granulocytes	NULL
,	NULL
myeloid-derived	NULL
dendritic	NULL
cells	NULL
,	NULL
and	NULL
B	NULL
lymphocytes	NULL
fail	NULL
to	NULL
develop	NULL
in	NULL
PU.1I~~-	NULL
mice	NULL
.	NULL
``	NULL

T-cell	NULL
development	NULL
is	NULL
also	NULL
strongly	NULL
affected	NULL
,	NULL
with	NULL
few	NULL
or	NULL
no	NULL
T	NULL
cells	NULL
developing	NULL
in	NULL
PU.1~~-mice	NULL
``	NULL
or	NULL
in	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
.	NULL
``	NULL

''	NULL
In	NULL
contrast	NULL
,	NULL
because	NULL
PU.1~	NULL
``	NULL
~	NULL
mice	NULL
die	NULL
at	NULL
E17.5	NULL
during	NULL
embryonic	NULL
life	NULL
``	NULL
``	NULL
or	NULL
just	NULL
after	NULL
birth	NULL
,	NULL
``	NULL
``	NULL
the	NULL
role	NULL
of	NULL
PU.1	NULL
in	NULL
NK	NULL
cell	NULL
differentiation	NULL
has	NULL
not	NULL
been	NULL
examined	NULL
.	NULL

To	NULL
overcome	NULL
this	NULL
limitation	NULL
,	NULL
we	NULL
utilized	NULL
a	NULL
recently	NULL
developed	NULL
complementation	NULL
system	NULL
in	NULL
which	NULL
fetal	NULL
liver	NULL
(	NULL
FL	NULL
)	NULL
cells	NULL
are	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
(	NULL
HSCs	NULL
)	NULL
to	NULL
reconstitute	NULL
alymphoid	NULL
Rag2/yc-	NULL
``	NULL
~-	NULL
mice	NULL
.	NULL

In	NULL
these	NULL
hematopoietic	NULL
chimeras	NULL
,	NULL
all	NULL
lymphoid	NULL
cells	NULL
are	NULL
donor	NULL
derived	NULL
.	NULL
``	NULL

We	NULL
found	NULL
that	NULL
PU.1~~-Rag2/yc	NULL
``	NULL
-	NULL
hematopoietic	NULL
chimeras	NULL
were	NULL
essentially	NULL
devoid	NULL
of	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
NK	NULL
cells	NULL
could	NULL
be	NULL
generated	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
sharing	NULL
a	NULL
close	NULL
developmental	NULL
relationship	NULL
,	NULL
B	NULL
,	NULL
T	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
are	NULL
differentially	NULL
dependent	NULL
on	NULL
PU.1	NULL
for	NULL
their	NULL
generation	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Mice	NULL
and	NULL
generation	NULL
of	NULL
FL	NULL
hematopoietic	NULL
chimeras	NULL
Mice	NULL
with	NULL
a	NULL
null	NULL
mutation	NULL
in	NULL
the	NULL
common	NULL
y	NULL
chain	NULL
were	NULL
from	NULL
the	NULL
fourth	NULL
generation	NULL
backcross	NULL
to	NULL
the	NULL
C57BI1/6	NULL
background	NULL
.	NULL

Rag2~	NULL
mice	NULL
(	NULL
10th	NULL
backcross	NULL
to	NULL
C57B1/6	NULL
)	NULL
were	NULL
bred	NULL
with	NULL
B10.BR	NULL
(	NULL
H-25	NULL
)	NULL
,	NULL
and	NULL
F1	NULL
progeny	NULL
were	NULL
intercrossed	NULL
to	NULL
generate	NULL
RAG-2-deficient	NULL
mice	NULL
on	NULL
the	NULL
H-2	NULL
«	NULL
background	NULL
.	NULL

These	NULL
mice	NULL
were	NULL
then	NULL
bred	NULL
with	NULL
Rag2/yc	NULL
'~	NULL
mice	NULL
to	NULL
generate	NULL
Rag2/yc	NULL
'~	NULL
mice	NULL
carrying	NULL
the	NULL
H-2	NULL
«	NULL
haplotype	NULL
.	NULL

PU.1~	NULL
``	NULL
+*	NULL
mice	NULL
!	NULL
``	NULL

(	NULL
C57B1/6	NULL
X	NULL
129	NULL
,	NULL
H-2	NULL
``	NULL
)	NULL
were	NULL
screened	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
,	NULL
using	NULL
genomic	NULL
DNA	NULL
and	NULL
specific	NULL
primers	NULL
for	NULL
PU.1	NULL
and	NULL
Neo	NULL
gene	NULL
(	NULL
5'-CGG	NULL
ATG	NULL
TGC	NULL
TTC	NULL
CCT	NULL
TAT	NULL
CAA	NULL
AC-3	NULL
``	NULL
,	NULL
5'-TGA	NULL
CTT	NULL
TCT	NULL
TCA	NULL
CCT	NULL
CGC	NULL
CTG	NULL
TC-3	NULL
'	NULL
,	NULL
5-CAG	NULL
AAA	NULL
GCG	NULL
AAG	NULL
GAG	NULL
CAA	NULL
AGC	NULL
TG-3	NULL
'	NULL
)	NULL
.	NULL

PU.1*	NULL
``	NULL
~	NULL
mice	NULL
were	NULL
intercrossed	NULL
.	NULL

to	NULL
generate	NULL
PU.1~	NULL
``	NULL
~	NULL
and	NULL
control	NULL
(	NULL
PU.1+*	NULL
``	NULL
*	NULL
,	NULL
or	NULL
PU.1*	NULL
``	NULL
~	NULL
,	NULL
thereafter	NULL
referred	NULL
to	NULL
as	NULL
WT	NULL
)	NULL
embryos	NULL
.	NULL

The	NULL
morning	NULL
of	NULL
the	NULL
vaginal	NULL
plug	NULL
discovery	NULL
was	NULL
designated	NULL
as	NULL
day	NULL
0.5	NULL
of	NULL
gestation	NULL
.	NULL

FL	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
day	NULL
15.5	NULL
embryos	NULL
by	NULL
passage	NULL
of	NULL
the	NULL
tissue	NULL
through	NULL
a	NULL
23-gauge	NULL
needle	NULL
,	NULL
and	NULL
the	NULL
genotypes	NULL
were	NULL
determined	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
,	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
Mac-1	NULL
(	NULL
macrophages	NULL
fail	NULL
to	NULL
develop	NULL
in	NULL
PU.1~~	NULL
embryos	NULL
)	NULL
``	NULL
Rag2/ye	NULL
'~	NULL
mice	NULL
on	NULL
H-2	NULL
«	NULL
background	NULL
(	NULL
>	NULL
6	NULL
weeks	NULL
of	NULL
age	NULL
)	NULL
were	NULL
irradiated	NULL
with	NULL
300	NULL
rads	NULL
from	NULL
a	NULL
cobalt	NULL
source	NULL
and	NULL
2	NULL
hours	NULL
later	NULL
injected	NULL
intravenously	NULL
with	NULL
8	NULL
,	NULL
25	NULL
,	NULL
or	NULL
75	NULL
X	NULL
10°	NULL
FL	NULL
cells	NULL
as	NULL
a	NULL
source	NULL
of	NULL
hematopoietic	NULL
progenitors	NULL
,	NULL
including	NULL
HSCs	NULL
,	NULL
which	NULL
we	NULL
will	NULL
refer	NULL
to	NULL
as	NULL
FL-HSCs	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
and	NULL
cell	NULL
sorting	NULL
Single	NULL
cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
from	NULL
blood	NULL
,	NULL
thymus	NULL
,	NULL
BM	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
liver	NULL
.	NULL

Erythrocytes	NULL
were	NULL
lysed	NULL
in	NULL
ammonium	NULL
chloride	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
with	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
and	NULL
0.01	NULL
%	NULL
sodium	NULL
azide	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
evaluated	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
(	NULL
mAbs	NULL
)	NULL
directly	NULL
conjugated	NULL
to	NULL
fluores-cein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
,	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
,	NULL
Tricolor	NULL
(	NULL
TRI	NULL
)	NULL
,	NULL
allophyco-cyanin	NULL
(	NULL
APC	NULL
)	NULL
,	NULL
or	NULL
biotin	NULL
were	NULL
used	NULL
for	NULL
immunofluorescence	NULL
analysis	NULL
,	NULL
including	NULL
mAbs	NULL
specific	NULL
for	NULL
immunoglobulin	NULL
M	NULL
(	NULL
IgM	NULL
)	NULL
,	NULL
IgD	NULL
,	NULL
T-cell	NULL
receptor	NULL
BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
aB	NULL
(	NULL
TCReB	NULL
)	NULL
,	NULL
TCRy8	NULL
,	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
CD11a	NULL
(	NULL
LFA-1	NULL
)	NULL
,	NULL
CD11b	NULL
(	NULL
Mac-1	NULL
)	NULL
,	NULL
CD19	NULL
,	NULL
CD45R	NULL
(	NULL
B220	NULL
)	NULL
,	NULL
CD90	NULL
(	NULL
Thy-1.2	NULL
)	NULL
,	NULL
CD117	NULL
(	NULL
c-kit	NULL
)	NULL
,	NULL
CD122	NULL
(	NULL
IL-2RfB	NULL
)	NULL
,	NULL
CD161	NULL
(	NULL
NK1.1	NULL
)	NULL
,	NULL
DX5	NULL
,	NULL
2B4	NULL
,	NULL
Ly49A	NULL
,	NULL
Ly49C/I	NULL
,	NULL
Ly49D	NULL
,	NULL
Ly49G2	NULL
,	NULL
Gr-1	NULL
,	NULL
TER-119	NULL
,	NULL
and	NULL
H-2*	NULL
(	NULL
all	NULL
from	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Biotin-conjugated	NULL
mAbs	NULL
were	NULL
revealed	NULL
by	NULL
streptavidin-TRI	NULL
(	NULL
Caltag	NULL
,	NULL
Burlingame	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
anti-FeyRI/III	NULL
(	NULL
hybridoma	NULL
24G2	NULL
)	NULL
for	NULL
20	NULL
minutes	NULL
on	NULL
ice	NULL
to	NULL
avoid	NULL
unspecific	NULL
binding	NULL
to	NULL
low	NULL
affinity	NULL
FcRs	NULL
.	NULL

Thereafter	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
biotinylated	NULL
and	NULL
fluorochrome-labeled	NULL
mAbs	NULL
at	NULL
saturating	NULL
concentrations	NULL
,	NULL
washed	NULL
twice	NULL
,	NULL
and	NULL
finally	NULL
incubated	NULL
with	NULL
streptavidin-TRL	NULL
.	NULL

To	NULL
evaluate	NULL
rare	NULL
BM	NULL
progenitor	NULL
populations	NULL
,	NULL
20	NULL
X	NULL
106	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
purified	NULL
rat	NULL
mAbs	NULL
for	NULL
lineage	NULL
(	NULL
Lin	NULL
)	NULL
markers	NULL
(	NULL
CD11b	NULL
,	NULL
CD19	NULL
,	NULL
TER-119	NULL
,	NULL
and	NULL
Gr-1	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
goat	NULL
antirat	NULL
IgG	NULL
coupled	NULL
with	NULL
magnetic	NULL
beads	NULL
(	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
,	NULL
and	NULL
the	NULL
majority	NULL
of	NULL
Lin*	NULL
cells	NULL
were	NULL
removed	NULL
on	NULL
a	NULL
magnet	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
stained	NULL
with	NULL
H-2	NULL
«	NULL
(	NULL
to	NULL
detect	NULL
host-derived	NULL
cells	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
rat	NULL
IgG	NULL
,	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
and	NULL
B220	NULL
(	NULL
all	NULL
coupled	NULL
with	NULL
TRI	NULL
)	NULL
.	NULL

TRI+*	NULL
cells	NULL
were	NULL
subsequently	NULL
electronically	NULL
gated	NULL
,	NULL
thereby	NULL
excluding	NULL
Lin*	NULL
and	NULL
host-derived	NULL
precursors	NULL
.	NULL

Analysis	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
FACScan	NULL
or	NULL
FACScalibur	NULL
flow	NULL
cytometer	NULL
,	NULL
using	NULL
the	NULL
Cellquest	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Dead	NULL
cells	NULL
were	NULL
excluded	NULL
by	NULL
means	NULL
of	NULL
their	NULL
forward	NULL
and	NULL
side	NULL
scatters	NULL
,	NULL
and	NULL
an	NULL
electronic	NULL
gate	NULL
was	NULL
set	NULL
to	NULL
acquire	NULL
10+	NULL
lymphoid	NULL
cells	NULL
.	NULL

Cells	NULL
derived	NULL
from	NULL
the	NULL
host	NULL
were	NULL
excluded	NULL
from	NULL
the	NULL
analysis	NULL
by	NULL
electronic	NULL
gating	NULL
.	NULL

To	NULL
purify	NULL
splenic	NULL
NK	NULL
cells	NULL
,	NULL
cell	NULL
suspensions	NULL
were	NULL
stained	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
NK1.1	NULL
,	NULL
and	NULL
CD3	NULL
and	NULL
NK	NULL
cells	NULL
(	NULL
CD3-NK1.1*	NULL
)	NULL
were	NULL
sorted	NULL
using	NULL
a	NULL
FACStar+	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
sorted	NULL
populations	NULL
was	NULL
reproducibility	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
.	NULL

NK	NULL
cell	NULL
lytic	NULL
activity	NULL
A	NULL
standard	NULL
*'Cr	NULL
release	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
measure	NULL
NK	NULL
lytic	NULL
activity	NULL
in	NULL
vitro	NULL
as	NULL
described	NULL
.	NULL

``	NULL
?	NULL

YAC-1	NULL
cells	NULL
(	NULL
mouse	NULL
thymoma	NULL
;	NULL
H-2*	NULL
)	NULL
were	NULL
used	NULL
as	NULL
target	NULL
cells	NULL
and	NULL
were	NULL
maintained	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
CM	NULL
;	NULL
RPMI-1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
105	NULL
M	NULL
B-ME	NULL
,	NULL
100	NULL
mg/mL	NULL
streptomycin	NULL
,	NULL
100	NULL
U/mL	NULL
penicillin	NULL
)	NULL
.	NULL

Target	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
100	NULL
Ci	NULL
5'Cr	NULL
(	NULL
ICN	NULL
Pharmaceuti-cal	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
2.5	NULL
to	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
graded	NULL
numbers	NULL
of	NULL
effector	NULL
cells	NULL
in	NULL
200	NULL
.L	NULL
medium	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Effector	NULL
cells	NULL
were	NULL
either	NULL
NK	NULL
cells	NULL
that	NULL
were	NULL
isolated	NULL
from	NULL
splenocytes	NULL
by	NULL
cell	NULL
sorting	NULL
or	NULL
IL-2-activated	NULL
NK	NULL
cell	NULL
cultures	NULL
.	NULL

The	NULL
radioactivity	NULL
released	NULL
into	NULL
the	NULL
cell-free	NULL
supernatant	NULL
was	NULL
measured	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
specific	NULL
lysis	NULL
was	NULL
calculated	NULL
as	NULL
follows	NULL
:	NULL
100	NULL
X	NULL
(	NULL
experimental	NULL
release	NULL
-	NULL
spontaneous	NULL
release	NULL
)	NULL
/	NULL
(	NULL
maximum	NULL
release	NULL
-	NULL
spontaneous	NULL
release	NULL
)	NULL
.	NULL

Reverse	NULL
transcriptase-PCR	NULL
and	NULL
Western	NULL
blotting	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
freshly	NULL
sorted	NULL
NK	NULL
cell	NULL
populations	NULL
with	NULL
RNABle	NULL
(	NULL
EUROBIO	NULL
,	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Complementary	NULL
DNA	NULL
was	NULL
synthesized	NULL
,	NULL
using	NULL
reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
from	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
(	NULL
PROMEGA	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
hexanucleo-tides	NULL
,	NULL
and	NULL
oligo-dT	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
,	NULL
using	NULL
Taq	NULL
Platinum	NULL
polymerase	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
.	NULL

Primer	NULL
sequences	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
PU.1	NULL
forward	NULL
5-GAG	NULL
TTT	NULL
GAG	NULL
AAC	NULL
TTC	NULL
CCT	NULL
GAG-3	NULL
'	NULL
and	NULL
reverse	NULL
TAG	NULL
GTC	NULL
ATC	NULL
TTC	NULL
TTG	NULL
CGG-3	NULL
'	NULL
;	NULL
Ets-1	NULL
forward	NULL
5'-CTA	NULL
CGG	NULL
TAT	NULL
CGA	NULL
GCA	NULL
TGC	NULL
TCA	NULL
GTG-3	NULL
'	NULL
and	NULL
reverse	NULL
5'-AAG	NULL
GTG	NULL
TCT	NULL
GTC	NULL
TGG	NULL
AGA	NULL
GGG	NULL
TCC-3	NULL
``	NULL
;	NULL
142	NULL
forward	NULL
5-TCT	NULL
GAG	NULL
CTT	NULL
ATG	NULL
TCG	NULL
AAT	NULL
GAT	NULL
AGC-3	NULL
'	NULL
and	NULL
reverse	NULL
AGC	NULL
ATT	NULL
CAG	NULL
TAG	NULL
GCT	NULL
CGT	NULL
GTC-3	NULL
'	NULL
;	NULL
IL-7Ra	NULL
forward	NULL
5'-CTT	NULL
TTA	NULL
CGA	NULL
GTG	NULL
AAA	NULL
TGC	NULL
CTA	NULL
ACT-3	NULL
'	NULL
and	NULL
reverse	NULL
5-CAG	NULL
GTA	NULL
TGA	NULL
TTC	NULL
AAG	NULL
AAT	NULL
GCA	NULL
ATA	NULL
CA-3	NULL
'	NULL
;	NULL
TCB-1	NULL
forward	NULL
TGC	NULL
CTT	NULL
CAA	NULL
TCT	NULL
GCT	NULL
CAT-3	NULL
'	NULL
and	NULL
reverse	NULL
5'-TGG	NULL
GTT	NULL
CTG	NULL
CCT	NULL
GTG	NULL
TTT	NULL
TCA-3	NULL
``	NULL
'	NULL
;	NULL
hypoxan-thine	NULL
phospho	NULL
ribosyl	NULL
transferase	NULL
(	NULL
HPRT	NULL
)	NULL
forward	NULL
5-CAC	NULL
AGG	NULL
ACT	NULL
AGA	NULL
ACA	NULL
CCT	NULL
GC-3	NULL
'	NULL
and	NULL
reverse	NULL
5-GCT	NULL
GGT	NULL
GAA	NULL
AAG	NULL
GAC	NULL
CTC	NULL
T-3	NULL
'	NULL
(	NULL
RNA	NULL
control	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
extracted	NULL
from	NULL
cell	NULL
lysates	NULL
derived	NULL
from	NULL
splenocytes	NULL
,	NULL
thymocytes	NULL
,	NULL
pre-B	NULL
cells	NULL
(	NULL
cell	NULL
line	NULL
18.81	NULL
)	NULL
,	NULL
and	NULL
purified	NULL
IL-2-activated	NULL
NK	NULL
cells	NULL
.	NULL

Proteins	NULL
were	NULL
then	NULL
resolved	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacryl-amide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

Immunoreactive	NULL
PU.1	NULL
protein	NULL
was	NULL
revealed	NULL
with	NULL
an	NULL
affinity-purified	NULL
rabbit	NULL
anti-PU.1	NULL
antibody	NULL
as	NULL
described	NULL
.	NULL
``	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
Thy	NULL
_-	NULL
Spl	NULL
_	NULL
Pre-B	NULL
F	NULL
i	NULL
chk	NULL
re	NULL
NK	NULL
Figure	NULL
1	NULL
.	NULL

NK	NULL
cells	NULL
express	NULL
PU.1	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
generated	NULL
from	NULL
thymocytes	NULL
,	NULL
splenocytes	NULL
,	NULL
pre-B	NULL
cells	NULL
(	NULL
cell	NULL
line	NULL
18.81	NULL
)	NULL
,	NULL
and	NULL
purified	NULL
splenic	NULL
IL-2-activated	NULL
NK	NULL
cells	NULL
.	NULL

Protein	NULL
extracts	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
probed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
affinity-purified	NULL
anti-PU.1	NULL
antibody	NULL
.	NULL

Blots	NULL
were	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
antitubulin	NULL
antibody	NULL
to	NULL
control	NULL
for	NULL
sample	NULL
loading	NULL
.	NULL

PU.1	NULL
Tubulin	NULL
.	NULL

Cell-cycle	NULL
analysis	NULL
Cell-cycle	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
in	NULL
vitro	NULL
IL-2-activated	NULL
NK	NULL
cells	NULL
and	NULL
on	NULL
circulating	NULL
CD3-NK1.1+	NULL
%	NULL
NK	NULL
cells	NULL
from	NULL
peripheral	NULL
blood	NULL
,	NULL
using	NULL
7-aminoactinomycin-D	NULL
(	NULL
7-AAD	NULL
)	NULL
incorporation	NULL
into	NULL
saponin-permeabilized	NULL
cells	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Sorted	NULL
splenic	NULL
CD3-NK1.1*	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
10+	NULL
cells/well	NULL
in	NULL
round-bottom	NULL
microtitre	NULL
plates	NULL
in	NULL
200	NULL
L	NULL
CM	NULL
and	NULL
activated	NULL
with	NULL
1000	NULL
U/mL	NULL
hulL-2	NULL
(	NULL
Peprotech	NULL
,	NULL
Rocky	NULL
Hill	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
7	NULL
days	NULL
.	NULL

To	NULL
stimulate	NULL
NK	NULL
cell	NULL
proliferation	NULL
and	NULL
to	NULL
promote	NULL
subsequent	NULL
activation-induced	NULL
cell	NULL
death	NULL
,	NULL
2	NULL
ng/mL	NULL
mIL-12	NULL
(	NULL
Peprotech	NULL
)	NULL
was	NULL
added	NULL
during	NULL
the	NULL
final	NULL
48	NULL
hours	NULL
before	NULL
the	NULL
cell-cycle	NULL
analysis	NULL
.	NULL

Statistical	NULL
analysis	NULL
Data	NULL
were	NULL
analyzed	NULL
with	NULL
the	NULL
Microsoft	NULL
Excel	NULL
software	NULL
,	NULL
applying	NULL
the	NULL
paired	NULL
Student	NULL
£	NULL
test	NULL
.	NULL

The	NULL
null	NULL
hypothesis	NULL
was	NULL
rejected	NULL
,	NULL
and	NULL
difference	NULL
was	NULL
assumed	NULL
significant	NULL
when	NULL
P	NULL
<	NULL
.05	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
PU.1	NULL
in	NULL
NK	NULL
cells	NULL
Previous	NULL
studies	NULL
have	NULL
assessed	NULL
PU.1	NULL
expression	NULL
in	NULL
CLPs	NULL
,	NULL
immature	NULL
B-	NULL
and	NULL
T-cell	NULL
precursors	NULL
,	NULL
and	NULL
mature	NULL
B	NULL
cells.2	NULL
>	NULL
``	NULL
2	NULL
``	NULL
However	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
PU.1	NULL
expression	NULL
in	NULL
NK	NULL
cells	NULL
and	NULL
its	NULL
putative	NULL
role	NULL
during	NULL
NK	NULL
cell	NULL
differentiation	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
tested	NULL
and	NULL
found	NULL
PU.1	NULL
protein	NULL
in	NULL
cell	NULL
lysates	NULL
derived	NULL
from	NULL
sorted	NULL
NK	NULL
cells	NULL
expanded	NULL
in	NULL
IL-2	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
PU.1	NULL
was	NULL
also	NULL
found	NULL
in	NULL
control	NULL
lysates	NULL
derived	NULL
from	NULL
total	NULL
splenocytes	NULL
and	NULL
pre-B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
thymocyte	NULL
lysates	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
mature	NULL
NK	NULL
cells	NULL
,	NULL
like	NULL
B	NULL
cells	NULL
and	NULL
unlike	NULL
T	NULL
cells	NULL
,	NULL
maintain	NULL
PU.1	NULL
expression	NULL
throughout	NULL
development	NULL
.	NULL

Lymphoid	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
To	NULL
address	NULL
the	NULL
role	NULL
of	NULL
PU.1	NULL
in	NULL
NK	NULL
cell	NULL
development	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
generated	NULL
hematopoietic	NULL
chimeras	NULL
by	NULL
injecting	NULL
PU.I~~-	NULL
or	NULL
WT	NULL
FL-HSCs	NULL
(	NULL
H-2	NULL
``	NULL
)	NULL
into	NULL
alymphoid	NULL
Reg2/yec-~	NULL
(	NULL
H-28	NULL
)	NULL
mice	NULL
.	NULL

In	NULL
this	NULL
system	NULL
,	NULL
``	NULL
``	NULL
all	NULL
lymphoid	NULL
cells	NULL
are	NULL
donor	NULL
derived	NULL
,	NULL
and	NULL
any	NULL
host-derived	NULL
cell	NULL
can	NULL
be	NULL
identified	NULL
by	NULL
virtue	NULL
of	NULL
their	NULL
differential	NULL
H-2	NULL
expression	NULL
.	NULL

Because	NULL
PU.1~	NULL
``	NULL
~-	NULL
FL	NULL
cells	NULL
are	NULL
known	NULL
to	NULL
contain	NULL
fewer	NULL
hematopoietic	NULL
progenitors	NULL
than	NULL
control	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
the	NULL
reconstitution	NULL
capacity	NULL
of	NULL
3	NULL
different	NULL
doses	NULL
(	NULL
8	NULL
X	NULL
10°	NULL
,	NULL
25	NULL
X	NULL
10°	NULL
,	NULL
or	NULL
75	NULL
X	NULL
10°	NULL
)	NULL
of	NULL
Table	NULL
1	NULL
.	NULL

Splenic	NULL
cellularity	NULL
(	NULL
cell	NULL
numbers	NULL
x	NULL
105	NULL
)	NULL
NK	NULL
CELLS	NULL
IN	NULL
PU.1~-	NULL
MICE	NULL
_	NULL
2627	NULL
FL-HSCs	NULL
from	NULL
PU.I~	NULL
``	NULL
~	NULL
embryos	NULL
was	NULL
analyzed	NULL
and	NULL
compared	NULL
to	NULL
WT	NULL
controls	NULL
.	NULL

Seven	NULL
to	NULL
13	NULL
weeks	NULL
after	NULL
the	NULL
transfer	NULL
,	NULL
chimeras	NULL
were	NULL
killed	NULL
,	NULL
and	NULL
the	NULL
lymphoid	NULL
cellularity	NULL
in	NULL
thymus	NULL
,	NULL
BM	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
liver	NULL
was	NULL
evaluated	NULL
.	NULL

Splenic	NULL
T	NULL
cells	NULL
(	NULL
CD3*+NK1.1~	NULL
)	NULL
were	NULL
virtually	NULL
absent	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
thymi	NULL
of	NULL
PU.1~	NULL
``	NULL
-chimeras	NULL
were	NULL
hypocellular	NULL
,	NULL
containing	NULL
almost	NULL
exclusively	NULL
early	NULL
CD4-CD8~	NULL
double-negative	NULL
thymocytes	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
very	NULL
rare	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
,	NULL
we	NULL
could	NULL
detect	NULL
the	NULL
4	NULL
populations	NULL
of	NULL
CD4*	NULL
,	NULL
CD4*CD8*	NULL
,	NULL
CD8*	NULL
,	NULL
and	NULL
CD4-CD8~	NULL
thymocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
variable	NULL
penetrance	NULL
of	NULL
the	NULL
T-cell-deficiency	NULL
phenotype	NULL
.	NULL
``	NULL

B220+IgM*+*	NULL
B	NULL
cells	NULL
were	NULL
absent	NULL
in	NULL
the	NULL
spleen	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
and	NULL
BM	NULL
of	NULL
PU.1~~-	NULL
chimeras	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
confirming	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
PU.1	NULL
in	NULL
B-cell	NULL
differentiation	NULL
.	NULL

!	NULL
``	NULL

In	NULL
contrast	NULL
with	NULL
the	NULL
T-	NULL
and	NULL
B-cell	NULL
deficiency	NULL
,	NULL
CD3-NK1.1+*	NULL
NK	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
spleen	NULL
,	NULL
liver	NULL
,	NULL
and	NULL
BM	NULL
of	NULL
all	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
analyzed	NULL
(	NULL
n	NULL
=	NULL
16	NULL
)	NULL
,	NULL
although	NULL
they	NULL
were	NULL
reduced	NULL
in	NULL
absolute	NULL
numbers	NULL
compared	NULL
to	NULL
controls	NULL
(	NULL
n	NULL
=	NULL
11	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
peripheral	NULL
NK	NULL
cell	NULL
generation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
was	NULL
somewhat	NULL
slower	NULL
than	NULL
controls	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
a	NULL
phenomenon	NULL
already	NULL
described	NULL
for	NULL
the	NULL
in	NULL
vivo	NULL
generation	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
viable	NULL
PU.1-	NULL
``	NULL
~-	NULL
strain	NULL
``	NULL
``	NULL
and	NULL
the	NULL
in	NULL
vitro	NULL
generation	NULL
of	NULL
lymphoid-derived	NULL
PU.1-	NULL
``	NULL
~	NULL
dendritic	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
The	NULL
data	NULL
in	NULL
Table	NULL
1	NULL
demonstrate	NULL
that	NULL
by	NULL
injecting	NULL
more	NULL
PU	NULL
.	NULL
]	NULL

I~~-	NULL
FL-HSCs	NULL
,	NULL
more	NULL
NK	NULL
cells	NULL
could	NULL
be	NULL
generated	NULL
,	NULL
but	NULL
the	NULL
NK	NULL
cell	NULL
numbers	NULL
in	NULL
PU.I~	NULL
``	NULL
~	NULL
chimeras	NULL
never	NULL
reached	NULL
those	NULL
found	NULL
in	NULL
WT	NULL
chimeras	NULL
.	NULL

Thus	NULL
,	NULL
10-fold	NULL
less	NULL
PU.1~	NULL
``	NULL
~-NK	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
the	NULL
spleens	NULL
of	NULL
chimeras	NULL
generated	NULL
with	NULL
8	NULL
X	NULL
10°	NULL
FL-HSC	NULL
's	NULL
,	NULL
but	NULL
only	NULL
3-	NULL
to	NULL
4-fold	NULL
less	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
the	NULL
spleens	NULL
of	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
generated	NULL
with	NULL
25	NULL
X	NULL
10°	NULL
FL-HSCs	NULL
.	NULL

However	NULL
,	NULL
T-	NULL
and	NULL
B-cell	NULL
numbers	NULL
did	NULL
not	NULL
significantly	NULL
increase	NULL
with	NULL
higher	NULL
doses	NULL
of	NULL
FL-HSCs	NULL
and	NULL
remained	NULL
400-	NULL
to	NULL
6000-fold	NULL
reduced	NULL
compared	NULL
to	NULL
controls	NULL
.	NULL

The	NULL
numbers	NULL
of	NULL
NK	NULL
cells	NULL
generated	NULL
with	NULL
even	NULL
higher	NULL
doses	NULL
of	NULL
FL-HSCs	NULL
(	NULL
75	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
not	NULL
greater	NULL
than	NULL
those	NULL
obtained	NULL
by	NULL
injecting	NULL
25	NULL
X	NULL
10°	NULL
FL-HSC	NULL
's	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
reduction	NULL
of	NULL
NK	NULL
cells	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
is	NULL
not	NULL
only	NULL
due	NULL
to	NULL
the	NULL
reduced	NULL
frequency	NULL
of	NULL
progenitors	NULL
in	NULL
the	NULL
FL	NULL
of	NULL
PU.I~	NULL
``	NULL
~	NULL
embryo	NULL
donors	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrate	NULL
that	NULL
NK	NULL
cell	NULL
development	NULL
is	NULL
permissive	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
.	NULL

Reduced	NULL
production	NULL
of	NULL
early	NULL
NK	NULL
cell	NULL
precursors	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
HSCs	NULL
of	NULL
PU.1~~	NULL
embryos	NULL
fail	NULL
to	NULL
express	NULL
VLA-4/CD49d~	NULL
VLA-5/CD49e-CD11b	NULL
integrins	NULL
that	NULL
has	NULL
been	NULL
hypothesized	NULL
to	NULL
result	NULL
in	NULL
defective	NULL
homing	NULL
to	NULL
the	NULL
BM	NULL
.	NULL
``	NULL

To	NULL
directly	NULL
test	NULL
whether	NULL
defects	NULL
in	NULL
engraftment	NULL
of	NULL
PU.1~	NULL
``	NULL
~-	NULL
FL-HSCs	NULL
in	NULL
the	NULL
adult	NULL
BM	NULL
could	NULL
explain	NULL
the	NULL
lower	NULL
numbers	NULL
of	NULL
NK	NULL
cells	NULL
in	NULL
PU.1~	NULL
``	NULL
~-chimeras	NULL
,	NULL
we	NULL
searched	NULL
for	NULL
donor-derived	NULL
HSCs	NULL
8	NULL
weeks	NULL
post-transfer	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
contained	NULL
in	NULL
a	NULL
population	NULL
of	NULL
BM	NULL
cells	NULL
that	NULL
is	NULL
negative	NULL
for	NULL
the	NULL
host	NULL
H-2	NULL
%	NULL
,	NULL
does	NULL
not	NULL
express	NULL
lineage-specific	NULL
markers	NULL
(	NULL
including	NULL
CD19	NULL
,	NULL
B220	NULL
,	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
Gr-1	NULL
,	NULL
Mac-1	NULL
,	NULL
TER-119	NULL
,	NULL
and	NULL
NK	NULL
1.1	NULL
)	NULL
,	NULL
and	NULL
is	NULL
positive	NULL
for	NULL
both	NULL
Sca-1	NULL
and	NULL
FL	NULL
cells	NULL
NK	NULL
cells	NULL
T	NULL
cells	NULL
B	NULL
cells	NULL
FL-HSC*	NULL
injected	NULL
Totalt	NULL
(	NULL
NK1.1+CD3-	NULL
)	NULL
(	NULL
NK1.1-CD3+	NULL
)	NULL
(	NULL
B220+IgM*	NULL
)	NULL
n	NULL
WT	NULL
8	NULL
518	NULL
+	NULL
147	NULL
5.2	NULL
£1	NULL
75.7	NULL
*	NULL
1.3	NULL
267	NULL
+	NULL
111	NULL
7	NULL
PU	NULL
.	NULL

1	NULL
-/-	NULL
8	NULL
47	NULL
+	NULL
23	NULL
0.48	NULL
+	NULL
0.29	NULL
0.21	NULL
+	NULL
0.18	NULL
0.04	NULL
+	NULL
0.02	NULL
8	NULL
WT	NULL
25	NULL
1250	NULL
+	NULL
243	NULL
16.1	NULL
*	NULL
1.2	NULL
206.6	NULL
+	NULL
98	NULL
429	NULL
+	NULL
99	NULL
4	NULL
PU.1-	NULL
!	NULL

-	NULL
25	NULL
96	NULL
+	NULL
46	NULL
3.7	NULL
+	NULL
3	NULL
0.2	NULL
+	NULL
0.1	NULL
0.2	NULL
+	NULL
0.1	NULL
8	NULL
NK	NULL
indicates	NULL
natural	NULL
killer	NULL
;	NULL
FL-HSC	NULL
,	NULL
fetal	NULL
liver	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
;	NULL
IgM	NULL
,	NULL
immunoglobulin	NULL
M	NULL
;	NULL
W7	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

*Genotype	NULL
of	NULL
FL-HSCs	NULL
used	NULL
to	NULL
reconstitute	NULL
alymphoid	NULL
Rag2/ye	NULL
'~	NULL
mice	NULL
.	NULL

{	NULL
Numbers	NULL
of	NULL
cells	NULL
found	NULL
in	NULL
the	NULL
spleen	NULL
of	NULL
reconstituted	NULL
Reag2/yc	NULL
'~	NULL
mice	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2628	NULL
-	NULL
COLUCCl	NULL
etal	NULL
BM	NULL
Spleen	NULL
Thymus	NULL
BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
Figure	NULL
2	NULL
.	NULL

NK	NULL
cells	NULL
but	NULL
not	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
generated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
.	NULL

Seven	NULL
to	NULL
13	NULL
weeks	NULL
after	NULL
transfer	NULL
of	NULL
Spleen	NULL
CD4	NULL
'on	NULL
Lymphoid	NULL
Granularity	NULL
NK1.1	NULL
a.	NULL
t	NULL
O	NULL
‘	NULL
00	NULL
50	NULL
‘	NULL
102	NULL
‘	NULL
Ol	NULL
1C	NULL
“	NULL
!	NULL

102	NULL
“	NULL
3J	NULL
10°	NULL
Tit	NULL
FL-HSCs	NULL
,	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
thymus	NULL
,	NULL
BM	NULL
,	NULL
and	NULL
spleen	NULL
and	NULL
were	NULL
stained	NULL
respectively	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
CD8-FITC	NULL
and	NULL
CD4-TRI	NULL
,	NULL
IgM-PE	NULL
and	NULL
B220-TRI	NULL
,	NULL
as	NULL
well	NULL
as	NULL
CD3-APC	NULL
and	NULL
NK1.1-PE	NULL
.	NULL

An	NULL
electronic	NULL
gate	NULL
based	NULL
on	NULL
mor-phologic	NULL
criteria	NULL
was	NULL
set	NULL
to	NULL
exclude	NULL
most	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

An	NULL
example	NULL
of	NULL
the	NULL
gating	NULL
strategy	NULL
for	NULL
lymphoid	NULL
cell	NULL
analysis	NULL
in	NULL
the	NULL
spleen	NULL
is	NULL
shown	NULL
.	NULL

Lymphoid	NULL
organs	NULL
of	NULL
PU.1~	NULL
``	NULL
~-	NULL
chimeras	NULL
contained	NULL
virtually	NULL
no	NULL
T	NULL
or	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
NK	NULL
cells	NULL
were	NULL
ol	NULL
ar	NULL
ae	NULL
aot	NULL
TU	NULL
Height	NULL
105	NULL
so	NULL
``	NULL
aot	NULL
Fido	NULL
Heign	NULL
CD8	NULL
IgM	NULL
c-kit	NULL
.	NULL

We	NULL
found	NULL
HSCs	NULL
(	NULL
Sca-1*	NULL
,	NULL
c-kit*	NULL
,	NULL
Lin-	NULL
,	NULL
and	NULL
H-2~	NULL
)	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
donor-derived	NULL
CD45	NULL
*	NULL
cells	NULL
at	NULL
16	NULL
weeks	NULL
post-transfer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
rule	NULL
out	NULL
a	NULL
major	NULL
defect	NULL
in	NULL
engraftment	NULL
or	NULL
homing	NULL
of	NULL
FL-HSC	NULL
's	NULL
in	NULL
PU.1~	NULL
``	NULL
~-	NULL
chimeras	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
PU.1	NULL
plays	NULL
an	NULL
intrinsic	NULL
and	NULL
essential	NULL
role	NULL
in	NULL
early	NULL
NK	NULL
cell	NULL
differentiation	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
identified	NULL
a	NULL
cell	NULL
population	NULL
in	NULL
murine	NULL
BM	NULL
that	NULL
appears	NULL
to	NULL
represent	NULL
a	NULL
committed	NULL
NK	NULL
cell	NULL
precursor	NULL
(	NULL
NKP	NULL
)	NULL
,	NULL
having	NULL
lost	NULL
any	NULL
potential	NULL
for	NULL
B	NULL
,	NULL
T	NULL
,	NULL
or	NULL
myeloid	NULL
differentiation	NULL
(	NULL
E.	NULL
Rosmaraki	NULL
et	NULL
al	NULL
,	NULL
manuscript	NULL
submitted	NULL
)	NULL
.	NULL

NKPs	NULL
are	NULL
Lin~	NULL
and	NULL
share	NULL
IL-2RB+*	NULL
expression	NULL
with	NULL
mature	NULL
NK	NULL
cells	NULL
,	NULL
but	NULL
in	NULL
contrast	NULL
they	NULL
do	NULL
not	NULL
express	NULL
NK1.1	NULL
or	NULL
DX5	NULL
.	NULL

Eight	NULL
to	NULL
10	NULL
weeks	NULL
after	NULL
the	NULL
transfer	NULL
,	NULL
we	NULL
enumerated	NULL
these	NULL
Lin-	NULL
IL-2RB+*	NULL
NK1.1-DX5	NULL
NKPs	NULL
in	NULL
WT	NULL
and	NULL
PU.1~-chimeras	NULL
.	NULL

NKPs	NULL
were	NULL
10-	NULL
to	NULL
12-fold	NULL
reduced	NULL
in	NULL
the	NULL
BM	NULL
of	NULL
PU.1~	NULL
``	NULL
-chimeras	NULL
(	NULL
Figure	NULL
3B	NULL
,	NULL
C	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
that	NULL
PU.1~	NULL
``	NULL
~-hematopoietic	NULL
progenitors	NULL
can	NULL
only	NULL
poorly	NULL
generate	NULL
the	NULL
early	NULL
NK	NULL
cell	NULL
compartment	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
numbers	NULL
of	NULL
NK	NULL
cells	NULL
in	NULL
older	NULL
PU.1~-	NULL
``	NULL
~	NULL
chimeras	NULL
(	NULL
>	NULL
30	NULL
weeks	NULL
;	NULL
n	NULL
=	NULL
5	NULL
)	NULL
decline	NULL
with	NULL
age	NULL
to	NULL
almost	NULL
undetectable	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
PU.1-	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
The	NULL
development	NULL
of	NULL
hematopoietic	NULL
progenitors	NULL
is	NULL
associated	NULL
with	NULL
dynamic	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
The	NULL
transcription	NULL
factors	NULL
Ets-1	NULL
and	NULL
Id2	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL
``	NULL

''	NULL
present	NULL
in	NULL
all	NULL
chimeras	NULL
analyzed	NULL
.	NULL

Data	NULL
are	NULL
from	NULL
representative	NULL
of	NULL
8	NULL
independent	NULL
experiments	NULL
.	NULL

PU.1-F-	NULL
Figure	NULL
4A	NULL
shows	NULL
that	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
express	NULL
Id2	NULL
transcripts	NULL
and	NULL
,	NULL
interestingly	NULL
,	NULL
up-regulate	NULL
expression	NULL
of	NULL
Ets-1	NULL
compared	NULL
to	NULL
control	NULL
NK	NULL
cells	NULL
.	NULL

We	NULL
further	NULL
analyzed	NULL
the	NULL
cell	NULL
surface	NULL
phenotype	NULL
of	NULL
the	NULL
splenic	NULL
NK	NULL
cells	NULL
that	NULL
developed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
.	NULL

A	NULL
series	NULL
of	NULL
differentiation	NULL
antigens	NULL
,	NULL
including	NULL
NK1.1	NULL
,	NULL
DX5	NULL
,	NULL
CD2	NULL
,	NULL
2B4	NULL
,	NULL
Mac-1	NULL
,	NULL
and	NULL
Thy-1	NULL
,	NULL
were	NULL
expressed	NULL
at	NULL
expected	NULL
frequencies	NULL
in	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
and	NULL
at	NULL
levels	NULL
comparable	NULL
to	NULL
those	NULL
of	NULL
controls	NULL
(	NULL
Figure	NULL
4B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
LFA-1	NULL
complex	NULL
is	NULL
expressed	NULL
on	NULL
all	NULL
leukocytes	NULL
and	NULL
is	NULL
composed	NULL
of	NULL
CD11a	NULL
and	NULL
CD18	NULL
integrins	NULL
.	NULL

CD11la	NULL
is	NULL
a	NULL
putative	NULL
target	NULL
gene	NULL
of	NULL
PU.1,5	NULL
>	NULL
2	NULL
nevertheless	NULL
PU.1~-	NULL
NK	NULL
cells	NULL
expressed	NULL
normal	NULL
levels	NULL
of	NULL
LFA-1	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Mature	NULL
NK	NULL
cells	NULL
express	NULL
inhibitory	NULL
and	NULL
activating	NULL
members	NULL
of	NULL
the	NULL
Ly49	NULL
family	NULL
of	NULL
receptors	NULL
that	NULL
recognize	NULL
MHC	NULL
class	NULL
I	NULL
antigens	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
target	NULL
cells	NULL
and	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
regulating	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
activity	NULL
(	NULL
reviewed	NULL
in	NULL
Raulet	NULL
``	NULL
``	NULL
)	NULL
.	NULL

PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
contained	NULL
normal	NULL
percentages	NULL
of	NULL
splenic	NULL
NK	NULL
cells	NULL
expressing	NULL
the	NULL
inhibitory	NULL
receptors	NULL
Ly49C/I	NULL
and	NULL
Ly49G2	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
NK	NULL
cell	NULL
fractions	NULL
expressing	NULL
the	NULL
inhibitory	NULL
receptor	NULL
Ly49A	NULL
and	NULL
the	NULL
activating	NULL
receptor	NULL
Ly49D	NULL
were	NULL
clearly	NULL
underrepresented	NULL
in	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Along	NULL
these	NULL
lines	NULL
,	NULL
the	NULL
Ly49a	NULL
locus	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
a	NULL
consensus	NULL
PU.1	NULL
binding	NULL
site	NULL
(	NULL
E.	NULL
Hofer	NULL
,	NULL
18th	NULL
International	NULL
NK	NULL
Cell	NULL
Workshop	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
,	NULL
May	NULL
2000	NULL
)	NULL
.	NULL

Reduced	NULL
Ly49A	NULL
expression	NULL
has	NULL
been	NULL
described	NULL
in	NULL
mice	NULL
deficient	NULL
for	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
transcription	NULL
factor	NULL
TCF-1	NULL
.	NULL

>	NULL
Figure	NULL
4A	NULL
shows	NULL
that	NULL
TCF-1	NULL
transcripts	NULL
were	NULL
normally	NULL
detected	NULL
in	NULL
PU.1~	NULL
``	NULL
-	NULL
A	NULL
B	NULL
C	NULL
,	NULL
HSC	NULL
=	NULL
0.09	NULL
%	NULL
4.8	NULL
£	NULL
1.2	NULL
x	NULL
10	NULL
%	NULL
IL-2RB+	NULL
Lin-€	NULL
2	NULL
&	NULL
C	NULL
e	NULL
:	NULL
6°	NULL
am	NULL
o	NULL
Al	NULL
6.6	NULL
%	NULL
-	NULL
76	NULL
%	NULL
LJ	NULL
E	NULL
~	NULL
3	NULL
QNO	NULL
lke	NULL
WT	NULL
Figure	NULL
3	NULL
.	NULL

Reduced	NULL
numbers	NULL
of	NULL
donor-derived	NULL
NK	NULL
cell	NULL
@	NULL
o	NULL
precursors	NULL
in	NULL
PU.1~~-	NULL
chimeras	NULL
.	NULL

(	NULL
A	NULL
)	NULL
BM	NULL
cells	NULL
of	NULL
WT	NULL
and	NULL
o	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
lineage-positive	NULL
cells	NULL
2	NULL
Pop	NULL
of	NULL
ot	NULL
i	NULL
as	NULL
were	NULL
eliminated	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
magnetic	NULL
bead	NULL
depletion	NULL
and	NULL
electronic	NULL
gating	NULL
.	NULL

HSCs	NULL
(	NULL
boxed	NULL
cells	NULL
)	NULL
were	NULL
identified	NULL
by	NULL
c-kit	NULL
and	NULL
Sca-1	NULL
expression	NULL
as	NULL
shown	NULL
.	NULL

Percentages	NULL
were	NULL
5.1	NULL
+	NULL
0.8	NULL
x	NULL
10°	NULL
IL-2R8+	NULL
Lin-calculated	NULL
on	NULL
total	NULL
BM	NULL
cells	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
4	NULL
E	NULL
»	NULL
C34	NULL
Ce	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Lin-depleted	NULL
BM	NULL
cells	NULL
were	NULL
in	NULL
m	NULL
,	NULL
_	NULL
|	NULL
1.9	NULL
%	NULL
92	NULL
%	NULL
parallel	NULL
stained	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
DX6-FITC	NULL
,	NULL
NK1.1-PE	NULL
,	NULL
a	NULL
;	NULL
~	NULL
y	NULL
and	NULL
IL-2RB-APC	NULL
.	NULL

Absolute	NULL
numbers	NULL
+	NULL
standard	NULL
deviation	NULL
of	NULL
L	NULL
2	NULL
Lin-depleted	NULL
BM	NULL
cells	NULL
are	NULL
indicated	NULL
on	NULL
top	NULL
of	NULL
the	NULL
dot	NULL
plots	NULL
.	NULL

3—0	NULL
PU.1-/-Lin-IL-2RB+	NULL
cells	NULL
were	NULL
electronically	NULL
gated	NULL
,	NULL
and	NULL
their	NULL
percent-	NULL
ages	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
percentages	NULL
of	NULL
gated	NULL
Lin-IL-2RB	NULL
*	NULL
09	NULL
>	NULL
SHA	NULL
,	NULL
...	NULL
.	NULL

,	NULL
cells	NULL
that	NULL
were	NULL
positive	NULL
or	NULL
negative	NULL
for	NULL
NK1.1	NULL
and	NULL
DX5	NULL
are	NULL
_	NULL
``	NULL
indicated	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
3	NULL
independent	NULL
experi-t	NULL
t	NULL
P	NULL
\—Don0r	NULL
derived	NULL
Lin	NULL
ments	NULL
,	NULL
including	NULL
8	NULL
WT	NULL
and	NULL
5	NULL
PU	NULL
.	NULL

1~~	NULL
chimeras	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
NK	NULL
CELLS	NULL
IN	NULL
PU	NULL
.	NULL

1~	NULL
``	NULL
-	NULL
MICE	NULL
_	NULL
2629	NULL
Figure	NULL
4	NULL
.	NULL

Characterization	NULL
of	NULL
PU.1~~	NULL
NK	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RT-	NULL
WT	NULL
-	NULL
PU.1-/-PCR	NULL
for	NULL
the	NULL
indicated	NULL
transcripts	NULL
was	NULL
performed	NULL
,	NULL
using	NULL
RNA	NULL
_	NULL
Af	NULL
pu.1	NULL
(	NULL
MK	NULL
prepared	NULL
from	NULL
sorted	NULL
splenic	NULL
NK	NULL
cells	NULL
(	NULL
CD3~NK1.1+*	NULL
)	NULL
from	NULL
*	NULL
r	NULL
WT	NULL
and	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Splenic	NULL
NK	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
the	NULL
indicated	NULL
surface	NULL
antigens	NULL
.	NULL

Histo-	NULL
Ets.1	NULL
|	NULL
M2800	NULL
meme	NULL
gram	NULL
profiles	NULL
are	NULL
shown	NULL
for	NULL
CD3-~NK1.1*	NULL
gated	NULL
cells	NULL
.	NULL

Data	NULL
s	NULL
are	NULL
representative	NULL
of	NULL
8	NULL
independent	NULL
experiments	NULL
.	NULL

1d2	NULL
|	NULL
Wilk	NULL
»	NULL
Waze	NULL
TCFL1	NULL
(	NULL
eved	NULL
|	NULL
HPRT	NULL
-	NULL
ammmee	NULL
memes	NULL
B	NULL
99	NULL
%	NULL
98	NULL
%	NULL
81	NULL
%	NULL
7.5	NULL
%	NULL
23	NULL
%	NULL
26	NULL
%	NULL
39	NULL
%	NULL
\	NULL
N	NULL
wT	NULL
97	NULL
%	NULL
99	NULL
%	NULL
84	NULL
%	NULL
1.1	NULL
%	NULL
2.3	NULL
%	NULL
28	NULL
%	NULL
30	NULL
%	NULL
A	NULL
A	NULL
PU	NULL
.	NULL

1-/-1	NULL
w	NULL
DX5	NULL
LFA1	NULL
Mac-1	NULL
Lyd49A	NULL
Ly49D	NULL
Ly49C/1	NULL
Ly49G2	NULL
NK	NULL
cells	NULL
,	NULL
excluding	NULL
the	NULL
possibility	NULL
that	NULL
PU.1	NULL
is	NULL
an	NULL
essential	NULL
regulator	NULL
of	NULL
TCF-1	NULL
expression	NULL
.	NULL

Mature	NULL
PU.1-	NULL
``	NULL
~-	NULL
NK	NULL
cells	NULL
fail	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
and	NULL
IL-12	NULL
A	NULL
survival	NULL
and/or	NULL
proliferation	NULL
defect	NULL
of	NULL
mature	NULL
NK	NULL
cells	NULL
could	NULL
contribute	NULL
to	NULL
the	NULL
reduced	NULL
absolute	NULL
numbers	NULL
of	NULL
NK	NULL
cells	NULL
in	NULL
PU.1~	NULL
``	NULL
-chimeras	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
measured	NULL
the	NULL
percentages	NULL
of	NULL
cycling	NULL
cells	NULL
and	NULL
hypodiploid	NULL
apoptotic	NULL
cells	NULL
among	NULL
circulating	NULL
NK	NULL
cells	NULL
in	NULL
PU.1-	NULL
``	NULL
~-	NULL
chimeras	NULL
.	NULL

Although	NULL
there	NULL
was	NULL
no	NULL
obvious	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
fraction	NULL
of	NULL
NK	NULL
cells	NULL
in	NULL
cycle	NULL
was	NULL
significantly	NULL
lower	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
controls	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

IL-2	NULL
mediates	NULL
survival	NULL
,	NULL
activation	NULL
,	NULL
and	NULL
expansion	NULL
of	NULL
NK	NULL
cells	NULL
in	NULL
vitro	NULL
,	NULL
``	NULL
and	NULL
addition	NULL
of	NULL
IL-12	NULL
to	NULL
IL-2-stimulated	NULL
NK	NULL
cells	NULL
promotes	NULL
their	NULL
activation-induced	NULL
cell	NULL
death	NULL
.	NULL

Purified	NULL
splenic	NULL
NK	NULL
cells	NULL
from	NULL
PU.1-	NULL
``	NULL
-	NULL
chimeras	NULL
remained	NULL
viable	NULL
throughout	NULL
the	NULL
culture	NULL
period	NULL
in	NULL
IL-2	NULL
but	NULL
did	NULL
not	NULL
appreciably	NULL
expand	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
they	NULL
proliferated	NULL
little	NULL
in	NULL
IL-12	NULL
,	NULL
although	NULL
a	NULL
normal	NULL
apoptotic	NULL
response	NULL
to	NULL
ano	NULL
sto	NULL
TMAD	NULL
(	NULL
DNA	NULL
content	NULL
}	NULL
Peripheral	NULL
NK	NULL
cells	NULL
(	NULL
blood	NULL
)	NULL
IL-12-activated	NULL
NK	NULL
cells	NULL
20	NULL
2	NULL
Apoptosis	NULL
i	NULL
Cycling	NULL
$	NULL
0	NULL
us	NULL
E	NULL
P	NULL
£0	NULL
,	NULL
I	NULL
wT	NULL
E4	NULL
9*4	NULL
13	NULL
%	NULL
a	NULL
19	NULL
%	NULL
&	NULL
#	NULL
\	NULL
o	NULL
3	NULL
s	NULL
]	NULL
(	NULL
een	NULL
sl	NULL
[	NULL
E	NULL
]	NULL
n	NULL
|	NULL
fat	NULL
wT	NULL
PU	NULL
.	NULL

1-4	NULL
Moo	NULL
C	NULL
``	NULL
IL-2-activated	NULL
NK	NULL
cells	NULL
5	NULL
m	NULL
%	NULL
80	NULL
Apoptosis	NULL
h	NULL
Cycling	NULL
~	NULL
60	NULL
E	NULL
«	NULL
|	NULL
\	NULL
PU	NULL
.	NULL

1-r	NULL
|	NULL
a	NULL
ao	NULL
1	NULL
%	NULL
0	NULL
dud	NULL
,	NULL
3	NULL
%	NULL
8	NULL
°	NULL
&	NULL
“	NULL
43171	NULL
;	NULL
Pag	NULL
a	NULL
``	NULL
so	NULL
~	NULL
Tho	NULL
DNA	NULL
content	NULL
(	NULL
ZAAD	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

Reduced	NULL
proliferation	NULL
in	NULL
PU.1~~	NULL
NK	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Blood	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
chimeras	NULL
4	NULL
weeks	NULL
after	NULL
the	NULL
transfer	NULL
of	NULL
FL-HSCs	NULL
.	NULL

The	NULL
figure	NULL
indicates	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
deviation	NULL
of	NULL
cycling	NULL
NK	NULL
cells	NULL
in	NULL
6	NULL
WT	NULL
and	NULL
6	NULL
PU.1~~	NULL
chimeras	NULL
;	NULL
*P	NULL
=.008	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Freshly	NULL
sorted	NULL
NK	NULL
cells	NULL
from	NULL
spleen	NULL
of	NULL
chimeras	NULL
were	NULL
plated	NULL
at	NULL
2	NULL
x	NULL
10+	NULL
cells/well	NULL
and	NULL
expanded	NULL
in	NULL
IL-2	NULL
for	NULL
7	NULL
days	NULL
,	NULL
and	NULL
thereafter	NULL
counted	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
same	NULL
cells	NULL
were	NULL
replated	NULL
at	NULL
10°	NULL
cells/well	NULL
and	NULL
further	NULL
stimulated	NULL
with	NULL
IL-12	NULL
overnight	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
apoptotic	NULL
and	NULL
proliferating	NULL
NK	NULL
cells	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
NK1.1-PE	NULL
and	NULL
further	NULL
stained	NULL
with	NULL
7-AAD	NULL
to	NULL
reveal	NULL
the	NULL
DNA	NULL
content	NULL
.	NULL

Proliferating	NULL
cells	NULL
(	NULL
in	NULL
GZ/M	NULL
)	NULL
contain	NULL
more	NULL
DNA	NULL
,	NULL
whereas	NULL
cells	NULL
dying	NULL
by	NULL
apoptosis	NULL
are	NULL
hypodiploid	NULL
.	NULL

IL-2	NULL
+	NULL
IL-12	NULL
was	NULL
preserved	NULL
(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
generate	NULL
NK	NULL
cells	NULL
in	NULL
vitro	NULL
from	NULL
PU.1~	NULL
``	NULL
~-	NULL
FL	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
cytokines	NULL
(	NULL
SCF	NULL
,	NULL
FIkK2L/FIt3L	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-2	NULL
)	NULL
that	NULL
drives	NULL
NK	NULL
cell	NULL
differentiation	NULL
with	NULL
high	NULL
efficiency	NULL
from	NULL
WT	NULL
FL	NULL
cells	NULL
.	NULL
``	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
have	NULL
defective	NULL
responses	NULL
to	NULL
cytokines	NULL
.	NULL

Expression	NULL
of	NULL
growth	NULL
factor	NULL
receptors	NULL
on	NULL
PU.1-	NULL
``	NULL
~-	NULL
NK	NULL
cells	NULL
PU.1	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cytokine	NULL
receptor	NULL
genes	NULL
.	NULL
``	NULL

Developing	NULL
NK	NULL
cell	NULL
precursors	NULL
rely	NULL
on	NULL
FIk2L/FIH3L	NULL
,	NULL
SCF	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-15	NULL
to	NULL
survive	NULL
,	NULL
proliferate	NULL
,	NULL
and	NULL
differentiate	NULL
(	NULL
reviewed	NULL
in	NULL
Williams	NULL
et	NULL
al	NULL
'	NULL
``	NULL
)	NULL
.	NULL

The	NULL
receptor	NULL
for	NULL
IL-7	NULL
is	NULL
expressed	NULL
during	NULL
the	NULL
early	NULL
lymphopoiesis	NULL
,	NULL
and	NULL
transcripts	NULL
for	NULL
the	NULL
IL-7Ra	NULL
chain	NULL
are	NULL
also	NULL
found	NULL
in	NULL
mature	NULL
NK	NULL
cells	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
failed	NULL
to	NULL
express	NULL
IL-7Ra	NULL
.	NULL

Interactions	NULL
of	NULL
SCF	NULL
with	NULL
its	NULL
c-kit	NULL
receptor	NULL
are	NULL
essential	NULL
for	NULL
expansion	NULL
of	NULL
NK	NULL
cell	NULL
precursors	NULL
and	NULL
full	NULL
maturation	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

?	NULL

A	NULL
small	NULL
subset	NULL
of	NULL
mature	NULL
NK	NULL
cells	NULL
express	NULL
the	NULL
c-kit	NULL
receptor	NULL
,	NULL
but	NULL
this	NULL
subset	NULL
was	NULL
6-	NULL
to	NULL
7-fold	NULL
reduced	NULL
in	NULL
PU.1~	NULL
``	NULL
-NK	NULL
cells	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
derived	NULL
from	NULL
c-kit-deficient	NULL
FL-HSCs	NULL
also	NULL
express	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
activation	NULL
marker	NULL
B220	NULL
.	NULL

``	NULL
>	NULL
Consistent	NULL
with	NULL
the	NULL
reduction	NULL
in	NULL
c-kit	NULL
expression	NULL
,	NULL
the	NULL
B220+	NULL
NK	NULL
A	NULL
WT	NULL
_	NULL
PU.1-/	NULL
--	NULL
|	NULL
ensue	NULL
B	NULL
98	NULL
%	NULL
10	NULL
%	NULL
32	NULL
%	NULL
{	NULL
M	NULL
wT	NULL
e	NULL
__|	NULL
H	NULL
97	NULL
%	NULL
1.6	NULL
%	NULL
6.5	NULL
%	NULL
\|	NULL
PU.1-/-n	NULL
win	NULL
IL-2RB	NULL
c-kit	NULL
©220	NULL
Figure	NULL
6	NULL
.	NULL

Expression	NULL
of	NULL
growth	NULL
factor	NULL
receptors	NULL
and	NULL
activation	NULL
markers	NULL
on	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RT-PCR	NULL
for	NULL
the	NULL
indicated	NULL
transcripts	NULL
was	NULL
performed	NULL
,	NULL
using	NULL
RNA	NULL
prepared	NULL
from	NULL
sorted	NULL
splenic	NULL
NK	NULL
cells	NULL
(	NULL
CD3-NK1.1+*	NULL
)	NULL
from	NULL
WT	NULL
and	NULL
PU.1~~	NULL
chimeras	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Splenic	NULL
NK	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
mAbs	NULL
specific	NULL
for	NULL
the	NULL
indicated	NULL
surface	NULL
antigens	NULL
.	NULL

Histogram	NULL
profiles	NULL
are	NULL
shown	NULL
for	NULL
CD3~NK1.1*	NULL
gated	NULL
cells	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
8	NULL
independent	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2630	NULL
-	NULL
COLUCCl	NULL
etal	NULL
cell	NULL
fraction	NULL
was	NULL
clearly	NULL
underrepresented	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
chimeras	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

Signaling	NULL
through	NULL
the	NULL
IL-15	NULL
receptor	NULL
is	NULL
crucial	NULL
to	NULL
drive	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL
``	NULL

''	NULL
This	NULL
tripartite	NULL
receptor	NULL
is	NULL
composed	NULL
of	NULL
the	NULL
IL-15Ra	NULL
,	NULL
IL-2RB	NULL
,	NULL
and	NULL
yc	NULL
chains	NULL
(	NULL
the	NULL
latter	NULL
2	NULL
are	NULL
shared	NULL
with	NULL
the	NULL
IL-2	NULL
receptor	NULL
and	NULL
can	NULL
signal	NULL
in	NULL
response	NULL
to	NULL
high	NULL
doses	NULL
of	NULL
IL-2	NULL
)	NULL
.	NULL

In	NULL
line	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
IL-2	NULL
to	NULL
promote	NULL
survival	NULL
of	NULL
PU.1~	NULL
``	NULL
~-	NULL
NK	NULL
cells	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
,	NULL
essentially	NULL
all	NULL
of	NULL
these	NULL
cells	NULL
expressed	NULL
IL-2RB	NULL
and	NULL
contained	NULL
RNA	NULL
transcripts	NULL
for	NULL
IL-15Ra	NULL
«	NULL
and	NULL
y	NULL
,	NULL
,	NULL
(	NULL
Figure	NULL
6B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Lytic	NULL
activity	NULL
of	NULL
PU.1-	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
We	NULL
have	NULL
previously	NULL
observed	NULL
a	NULL
correlation	NULL
between	NULL
reduced	NULL
expression	NULL
of	NULL
B220	NULL
and	NULL
defective	NULL
lytic	NULL
activity	NULL
in	NULL
c-kit'~	NULL
NK	NULL
cells	NULL
.	NULL
``	NULL

Because	NULL
B220	NULL
and	NULL
c-kit	NULL
expression	NULL
were	NULL
reduced	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
capacity	NULL
of	NULL
freshly	NULL
isolated	NULL
splenic	NULL
PU.1~~	NULL
NK	NULL
cells	NULL
to	NULL
lyse	NULL
YAC-1	NULL
thymoma	NULL
targets	NULL
in	NULL
a	NULL
standard	NULL
5'Cr	NULL
release	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7	NULL
,	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
were	NULL
fully	NULL
competent	NULL
in	NULL
lysing	NULL
this	NULL
NK-sensitive	NULL
target	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-2-activated	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
could	NULL
kill	NULL
both	NULL
YAC-1	NULL
and	NULL
P815	NULL
targets	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
differentiation	NULL
of	NULL
the	NULL
lytic	NULL
machinery	NULL
for	NULL
natural	NULL
cytolysis	NULL
does	NULL
not	NULL
require	NULL
PU.1	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
NK	NULL
cells	NULL
like	NULL
B	NULL
but	NULL
not	NULL
T	NULL
lymphocytes	NULL
express	NULL
PU.1	NULL
,	NULL
but	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
not	NULL
strictly	NULL
required	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
functional	NULL
NK	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Our	NULL
studies	NULL
made	NULL
use	NULL
of	NULL
a	NULL
novel	NULL
alymphoid	NULL
mouse	NULL
strain	NULL
,	NULL
Rag2/ye	NULL
~	NULL
mice	NULL
,	NULL
which	NULL
were	NULL
reconstituted	NULL
with	NULL
PU.1~	NULL
``	NULL
-	NULL
FL	NULL
hematopoietic	NULL
progenitors	NULL
.	NULL

In	NULL
this	NULL
setting	NULL
,	NULL
B-cell	NULL
,	NULL
T-cell	NULL
,	NULL
and	NULL
NK	NULL
cell	NULL
development	NULL
is	NULL
entirely	NULL
donor	NULL
derived	NULL
,	NULL
and	NULL
little	NULL
or	NULL
no	NULL
competition	NULL
with	NULL
endogenous	NULL
early	NULL
lymphoid	NULL
precursors	NULL
is	NULL
observed	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
the	NULL
potentially	NULL
lethal	NULL
effects	NULL
associated	NULL
with	NULL
defective	NULL
granulocyte	NULL
and	NULL
macrophage	NULL
development	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
are	NULL
avoided	NULL
since	NULL
these	NULL
hematopoietic	NULL
lineages	NULL
develop	NULL
normally	NULL
in	NULL
Rag2/yc-	NULL
``	NULL
~	NULL
mice	NULL
.	NULL
``	NULL

This	NULL
genetic	NULL
approach	NULL
allowed	NULL
us	NULL
to	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
PU.1	NULL
in	NULL
NK	NULL
differentiation	NULL
.	NULL

PU.1~~	NULL
chimeras	NULL
remain	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
deficient	NULL
but	NULL
generate	NULL
BM	NULL
precursors	NULL
and	NULL
peripheral	NULL
functional	NULL
NK	NULL
cells	NULL
,	NULL
although	NULL
both	NULL
are	NULL
reduced	NULL
in	NULL
numbers	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
NK	NULL
cells	NULL
maintain	NULL
expression	NULL
of	NULL
PU.1	NULL
throughout	NULL
differentiation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
mature	NULL
Exp	NULL
1	NULL
Exp	NULL
2	NULL
60	NULL
50	NULL
2	NULL
w	NULL
2	NULL
40	NULL
.S	NULL
O	NULL
30	NULL
©	NULL
o.	NULL
w	NULL
®	NULL
0	NULL
20	NULL
10	NULL
0	NULL
u	NULL
f	NULL
9	NULL
3	NULL
1	NULL
0.3	NULL
9	NULL
3	NULL
1	NULL
0.3	NULL
E/T	NULL
ratio	NULL
E/T	NULL
ratio	NULL
Figure	NULL
7	NULL
.	NULL

PU.1~~	NULL
NK	NULL
cells	NULL
are	NULL
able	NULL
to	NULL
lyse	NULL
tumor	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Splenic	NULL
CD3-~NK1.1+*	NULL
NK	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
sorting	NULL
and	NULL
were	NULL
used	NULL
as	NULL
effectors	NULL
in	NULL
a	NULL
classical	NULL
5	NULL
!	NULL

Cr	NULL
release	NULL
assay	NULL
versus	NULL
YAC-1	NULL
thymoma	NULL
cells	NULL
.	NULL

There	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
in	NULL
the	NULL
lytic	NULL
capacity	NULL
of	NULL
splenic	NULL
NK	NULL
cells	NULL
purified	NULL
from	NULL
PU	NULL
.	NULL

1~	NULL
``	NULL
~	NULL
(	NULL
0	NULL
)	NULL
or	NULL
WT	NULL
(	NULL
@	NULL
)	NULL
chimeras	NULL
.	NULL

Data	NULL
from	NULL
2	NULL
separate	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
displayed	NULL
phenotypical	NULL
abnormalities	NULL
,	NULL
such	NULL
as	NULL
reduced	NULL
expression	NULL
of	NULL
certain	NULL
surface	NULL
antigens	NULL
,	NULL
including	NULL
the	NULL
receptors	NULL
for	NULL
IL-7	NULL
and	NULL
SCF	NULL
,	NULL
and	NULL
defective	NULL
proliferative	NULL
responses	NULL
to	NULL
potent	NULL
NK	NULL
cell	NULL
mitogens	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
and	NULL
IL-12	NULL
.	NULL

However	NULL
,	NULL
PU.1-	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
could	NULL
mediate	NULL
natural	NULL
cytotoxicity	NULL
and	NULL
survive	NULL
in	NULL
vitro	NULL
on	NULL
stimulation	NULL
with	NULL
IL-2	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
results	NULL
demonstrate	NULL
a	NULL
differential	NULL
requirement	NULL
of	NULL
PU.1	NULL
for	NULL
NK	NULL
versus	NULL
B-	NULL
and	NULL
T-cell	NULL
lymphopoiesis	NULL
.	NULL

How	NULL
do	NULL
we	NULL
explain	NULL
the	NULL
partial	NULL
effects	NULL
of	NULL
PU.1	NULL
deficiency	NULL
on	NULL
NK	NULL
cell	NULL
differentiation	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
known	NULL
roles	NULL
that	NULL
this	NULL
transcription	NULL
factor	NULL
plays	NULL
during	NULL
hematopoiesis	NULL
?	NULL

PU.1	NULL
expression	NULL
appears	NULL
to	NULL
be	NULL
regulated	NULL
in	NULL
a	NULL
complex	NULL
and	NULL
dynamic	NULL
fashion	NULL
throughout	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

PU.1	NULL
is	NULL
expressed	NULL
in	NULL
HSCs	NULL
and	NULL
in	NULL
common	NULL
myeloid	NULL
progenitors	NULL
and	NULL
in	NULL
CLPs	NULL
.	NULL

``	NULL
®	NULL
Although	NULL
the	NULL
precise	NULL
effects	NULL
of	NULL
PU.1	NULL
deficiency	NULL
on	NULL
these	NULL
hematopoietic	NULL
subsets	NULL
remain	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
PU.1	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
HSCs	NULL
,	NULL
since	NULL
this	NULL
cell	NULL
subset	NULL
could	NULL
be	NULL
detected	NULL
after	NULL
cell	NULL
transfer	NULL
of	NULL
PU./~	NULL
``	NULL
~	NULL
FL	NULL
precursors	NULL
into	NULL
Rag2/yc	NULL
``	NULL
-	NULL
recipients	NULL
.	NULL

PU.1	NULL
is	NULL
essential	NULL
for	NULL
myeloid	NULL
differentiation	NULL
,	NULL
``	NULL
yet	NULL
its	NULL
absence	NULL
causes	NULL
divergent	NULL
consequences	NULL
in	NULL
distinct	NULL
cell	NULL
subsets	NULL
.	NULL

Monocytes	NULL
and	NULL
macrophages	NULL
strictly	NULL
depend	NULL
on	NULL
PU.1	NULL
for	NULL
develop-ment	NULL
,	NULL
``	NULL
whereas	NULL
neutrophils	NULL
can	NULL
develop	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
mice	NULL
,	NULL
although	NULL
they	NULL
show	NULL
defective	NULL
effector	NULL
functions	NULL
.	NULL
``	NULL

''	NULL
Myeloid-derived	NULL
dendritic	NULL
cells	NULL
also	NULL
fail	NULL
to	NULL
develop	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
,	NULL
whereas	NULL
the	NULL
requirement	NULL
for	NULL
PU.1	NULL
in	NULL
development	NULL
of	NULL
lymphoid-derived	NULL
dendritic	NULL
cells	NULL
is	NULL
controversial	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
PU.1	NULL
in	NULL
this	NULL
subset	NULL
has	NULL
not	NULL
been	NULL
documented	NULL
.	NULL

``	NULL
%	NULL
``	NULL
PU.1	NULL
expression	NULL
is	NULL
maintained	NULL
as	NULL
CLPs	NULL
differentiate	NULL
toward	NULL
the	NULL
B-cell	NULL
lineage	NULL
but	NULL
is	NULL
turned	NULL
off	NULL
early	NULL
in	NULL
T-cell	NULL
development.	NULL
``	NULL

?	NULL
``	NULL

The	NULL
requirement	NULL
of	NULL
PU.1	NULL
for	NULL
B-cell	NULL
development	NULL
appears	NULL
absolute	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
complete	NULL
absence	NULL
of	NULL
fetal	NULL
and	NULL
BM-derived	NULL
B	NULL
lineage	NULL
cells	NULL
in	NULL
PU.1~	NULL
``	NULL
~-	NULL
mice	NULL
,	NULL
'*	NULL
``	NULL
which	NULL
we	NULL
confirm	NULL
in	NULL
this	NULL
report	NULL
.	NULL

PU.1	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-7Ra	NULL
gene	NULL
during	NULL
fetal	NULL
PU	NULL
.	NULL

1~	NULL
``	NULL
~-	NULL
fetal	NULL
hematopoietic	NULL
progenitors	NULL
do	NULL
not	NULL
express	NULL
transcripts	NULL
for	NULL
the	NULL
B	NULL
lineage-specific	NULL
transcription	NULL
factors	NULL
EBF	NULL
and	NULL
Pax-5	NULL
.	NULL

'+	NULL
``	NULL
Thus	NULL
,	NULL
the	NULL
profound	NULL
block	NULL
to	NULL
B-cell	NULL
development	NULL
caused	NULL
by	NULL
the	NULL
PU	NULL
.	NULL
]	NULL

mutation	NULL
may	NULL
be	NULL
due	NULL
to	NULL
defects	NULL
in	NULL
both	NULL
IL-7-induced	NULL
proliferation	NULL
as	NULL
well	NULL
as	NULL
EBF	NULL
and	NULL
Pax-5-mediated	NULL
differentiation	NULL
of	NULL
B	NULL
lineage	NULL
progenitors	NULL
.	NULL

PU.1	NULL
may	NULL
directly	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
loci.4'*	NULL
Interestingly	NULL
,	NULL
low	NULL
levels	NULL
of	NULL
PU.1	NULL
are	NULL
essential	NULL
for	NULL
B-cell	NULL
development	NULL
,	NULL
whereas	NULL
high	NULL
levels	NULL
inhibit	NULL
B-cell	NULL
differentiation	NULL
and	NULL
instead	NULL
promote	NULL
macrophage	NULL
development	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
,	NULL
PU.1	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
discrete	NULL
stage	NULL
of	NULL
T	NULL
lineage	NULL
differentiation	NULL
.	NULL

Only	NULL
the	NULL
earliest	NULL
intrathymic	NULL
progenitors	NULL
(	NULL
CD44*CD25~	NULL
)	NULL
express	NULL
PU.1	NULL
,	NULL
which	NULL
is	NULL
rapidly	NULL
extinguished	NULL
as	NULL
T	NULL
cells	NULL
mature	NULL
.	NULL

``	NULL
>	NULL
``	NULL
``	NULL
Still	NULL
,	NULL
T-cell	NULL
development	NULL
is	NULL
profoundly	NULL
impaired	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
mice	NULL
.	NULL
``	NULL

However	NULL
,	NULL
studies	NULL
using	NULL
fetal	NULL
thymic	NULL
organ	NULL
culture	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
few	NULL
thymocytes	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
mice	NULL
that	NULL
can	NULL
bypass	NULL
this	NULL
developmental	NULL
block	NULL
develop	NULL
into	NULL
mature	NULL
T	NULL
cells	NULL
that	NULL
have	NULL
normal	NULL
function	NULL
,	NULL
``	NULL
thus	NULL
PU.1	NULL
expression	NULL
in	NULL
T-cell	NULL
differentiation	NULL
is	NULL
essential	NULL
only	NULL
during	NULL
early	NULL
thymopoiesis	NULL
.	NULL

CD44*CD25~	NULL
cells	NULL
of	NULL
fetal	NULL
thymi	NULL
contain	NULL
a	NULL
bipotent	NULL
precursor	NULL
endowed	NULL
with	NULL
both	NULL
NK	NULL
and	NULL
T	NULL
potential	NULL
,	NULL
*	NULL
``	NULL
and	NULL
PU.1	NULL
deficiency	NULL
may	NULL
block	NULL
development	NULL
of	NULL
these	NULL
2	NULL
closely	NULL
related	NULL
cell	NULL
lineages	NULL
.	NULL

However	NULL
,	NULL
this	NULL
bipotent	NULL
precursor	NULL
may	NULL
not	NULL
represent	NULL
the	NULL
main	NULL
pool	NULL
of	NULL
NK	NULL
progenitors	NULL
in	NULL
adult	NULL
life	NULL
,	NULL
when	NULL
NK	NULL
lymphopoiesis	NULL
occurs	NULL
in	NULL
the	NULL
BM	NULL
.	NULL

We	NULL
show	NULL
here	NULL
a	NULL
reduction	NULL
of	NULL
NKP	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
BM	NULL
,	NULL
whereas	NULL
their	NULL
frequency	NULL
of	NULL
HSCs	NULL
was	NULL
normal	NULL
.	NULL

This	NULL
suggests	NULL
a	NULL
NK	NULL
lineage-specific	NULL
role	NULL
for	NULL
PU.1	NULL
,	NULL
which	NULL
may	NULL
be	NULL
independent	NULL
of	NULL
its	NULL
role	NULL
in	NULL
early	NULL
T-cell	NULL
development	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
disrupts	NULL
hematopoietic	NULL
development	NULL
are	NULL
being	NULL
clarified	NULL
.	NULL

A	NULL
major	NULL
function	NULL
of	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
PU.1	NULL
is	NULL
to	NULL
control	NULL
the	NULL
transcription	NULL
of	NULL
growth	NULL
factor	NULL
receptor	NULL
genes	NULL
in	NULL
developing	NULL
blood	NULL
cells	NULL
.	NULL

!	NULL
``	NULL

In	NULL
the	NULL
context	NULL
of	NULL
myeloid	NULL
development	NULL
,	NULL
evidence	NULL
supports	NULL
a	NULL
model	NULL
in	NULL
which	NULL
PU.1	NULL
is	NULL
required	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
and	NULL
c-fms	NULL
receptors	NULL
on	NULL
early	NULL
myeloid	NULL
progenitors	NULL
(	NULL
see	NULL
Held	NULL
et	NULL
al	NULL
``	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

However	NULL
,	NULL
retroviral	NULL
infection	NULL
with	NULL
c-fms	NULL
could	NULL
only	NULL
restore	NULL
the	NULL
proliferation	NULL
but	NULL
not	NULL
differentiation	NULL
defect	NULL
in	NULL
PU.1-deficient	NULL
myeloid	NULL
precursors	NULL
,	NULL
suggesting	NULL
additional	NULL
roles	NULL
for	NULL
PU.1	NULL
in	NULL
macrophage	NULL
development	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
expression	NULL
of	NULL
certain	NULL
cytokine	NULL
receptors	NULL
during	NULL
early	NULL
myeloid	NULL
and	NULL
B-cell	NULL
development	NULL
in	NULL
PU.1	NULL
mutants	NULL
can	NULL
partly	NULL
explain	NULL
the	NULL
developmental	NULL
blocks	NULL
.	NULL

In	NULL
line	NULL
with	NULL
this	NULL
,	NULL
PU.1	NULL
deficiency	NULL
impaired	NULL
the	NULL
expression	NULL
of	NULL
some	NULL
cytokine	NULL
and	NULL
growth	NULL
factor	NULL
receptors	NULL
on	NULL
developing	NULL
NK	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
identified	NULL
4	NULL
ligand/receptor	NULL
systems	NULL
that	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
NK	NULL
cells	NULL
from	NULL
hematopoietic	NULL
precursors	NULL
:	NULL
Flk2/FIt3	NULL
,	NULL
c-kit	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-15	NULL
(	NULL
reviewed	NULL
in	NULL
Williams	NULL
et	NULL
al	NULL
``	NULL
``	NULL
)	NULL
.	NULL

Of	NULL
these	NULL
,	NULL
we	NULL
found	NULL
that	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
express	NULL
IL-2RB	NULL
and	NULL
transcripts	NULL
for	NULL
IL-15Ra	NULL
«	NULL
and	NULL
yc	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-7Ra	NULL
was	NULL
absent	NULL
,	NULL
and	NULL
c-kit	NULL
expression	NULL
was	NULL
reduced	NULL
on	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
reduction	NULL
in	NULL
numbers	NULL
of	NULL
NK	NULL
precursors	NULL
seen	NULL
in	NULL
PU.1~	NULL
``	NULL
-	NULL
BM	NULL
may	NULL
well	NULL
reflect	NULL
a	NULL
synergistic	NULL
effect	NULL
of	NULL
the	NULL
defective	NULL
IL-7Ra	NULL
«	NULL
and	NULL
c-kit	NULL
expression	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
c-kit	NULL
and	NULL
IL-7R	NULL
signaling	NULL
,	NULL
NK	NULL
cell	NULL
development	NULL
may	NULL
be	NULL
sustained	NULL
by	NULL
FIk2L/FIt3L	NULL
,	NULL
IL-15	NULL
,	NULL
or	NULL
other	NULL
cytokines	NULL
.	NULL

A	NULL
similar	NULL
cumulative	NULL
defect	NULL
in	NULL
these	NULL
cytokine	NULL
receptors	NULL
may	NULL
also	NULL
explain	NULL
the	NULL
severe	NULL
block	NULL
in	NULL
early	NULL
T	NULL
lymphopoiesis	NULL
in	NULL
PU.1-	NULL
``	NULL
~-	NULL
mice	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
the	NULL
requirement	NULL
for	NULL
IL-7	NULL
and	NULL
c-kit	NULL
in	NULL
early	NULL
NK	NULL
lymphopoiesis	NULL
may	NULL
be	NULL
less	NULL
strict	NULL
than	NULL
for	NULL
early	NULL
thymopoiesis	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
both	NULL
IL-7	NULL
and	NULL
c-kit	NULL
will	NULL
help	NULL
to	NULL
test	NULL
this	NULL
hypothesis	NULL
.	NULL

T-cell	NULL
progenitors	NULL
lose	NULL
the	NULL
expression	NULL
of	NULL
PU.1	NULL
as	NULL
they	NULL
commit	NULL
to	NULL
the	NULL
T	NULL
lineage	NULL
(	NULL
CD44*CD25*	NULL
)	NULL
,	NULL
whereas	NULL
NK	NULL
cells	NULL
express	NULL
it	NULL
throughout	NULL
development	NULL
.	NULL

In	NULL
line	NULL
with	NULL
this	NULL
,	NULL
mature	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
are	NULL
less	NULL
in	NULL
cycle	NULL
,	NULL
fail	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
mitogens	NULL
,	NULL
and	NULL
do	NULL
not	NULL
express	NULL
a	NULL
normal	NULL
pattern	NULL
of	NULL
surface	NULL
antigens	NULL
(	NULL
including	NULL
Ly49A	NULL
,	NULL
Ly49D	NULL
,	NULL
and	NULL
B220	NULL
)	NULL
as	NULL
they	NULL
differentiate	NULL
.	NULL

Yet	NULL
they	NULL
are	NULL
competent	NULL
for	NULL
natural	NULL
cytolysis	NULL
of	NULL
lymphomas	NULL
,	NULL
suggesting	NULL
that	NULL
PU.1-independent	NULL
transcriptional	NULL
regulation	NULL
governs	NULL
this	NULL
crucial	NULL
NK	NULL
cell	NULL
effector	NULL
function	NULL
.	NULL

Expression	NULL
of	NULL
Ly49	NULL
molecules	NULL
may	NULL
be	NULL
acquired	NULL
in	NULL
an	NULL
ordered	NULL
sequence	NULL
,	NULL
although	NULL
expression	NULL
patterns	NULL
of	NULL
genes	NULL
within	NULL
the	NULL
NK	NULL
cell	NULL
appear	NULL
to	NULL
be	NULL
regulated	NULL
independently	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
that	NULL
control	NULL
this	NULL
process	NULL
remain	NULL
ill	NULL
defined	NULL
.	NULL

We	NULL
found	NULL
that	NULL
PU.1	NULL
deficiency	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
selective	NULL
reduction	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
Ly49A	NULL
and	NULL
Ly49D	NULL
,	NULL
whereas	NULL
NK1.1	NULL
,	NULL
Ly49G2	NULL
,	NULL
and	NULL
Ly49C/I	NULL
were	NULL
normally	NULL
expressed	NULL
in	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
this	NULL
observation	NULL
awaits	NULL
further	NULL
investigation	NULL
but	NULL
indicates	NULL
that	NULL
PU.1	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
fine-tuning	NULL
of	NULL
Ly49	NULL
expression	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
PU.1	NULL
may	NULL
affect	NULL
the	NULL
acquisition	NULL
of	NULL
early	NULL
(	NULL
Ly49A	NULL
)	NULL
but	NULL
not	NULL
late	NULL
Ly49	NULL
(	NULL
Ly49C/I	NULL
)	NULL
members	NULL
.	NULL

The	NULL
TCF-1	NULL
transcription	NULL
factor	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
specific	NULL
regulation	NULL
of	NULL
Ly49A	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
we	NULL
References	NULL
NK	NULL
CELLS	NULL
IN	NULL
PU.1~-	NULL
MICE	NULL
_	NULL
2631	NULL
could	NULL
exclude	NULL
,	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
gene	NULL
expression	NULL
analysis	NULL
,	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
PU.1	NULL
on	NULL
TCE-1	NULL
expression	NULL
,	NULL
and	NULL
it	NULL
is	NULL
,	NULL
therefore	NULL
,	NULL
likely	NULL
that	NULL
the	NULL
defective	NULL
Ly49	NULL
expression	NULL
seen	NULL
in	NULL
PU.I~~	NULL
NK	NULL
cells	NULL
is	NULL
independent	NULL
of	NULL
TCF-1	NULL
,	NULL
although	NULL
TCF-1	NULL
and	NULL
PU.1	NULL
may	NULL
cooperate	NULL
to	NULL
activate	NULL
Ly49A	NULL
expression	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
comprises	NULL
multiple	NULL
members	NULL
,	NULL
and	NULL
,	NULL
although	NULL
their	NULL
expression	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
dynamic	NULL
way	NULL
during	NULL
development	NULL
,	NULL
overlapping	NULL
expression	NULL
patterns	NULL
of	NULL
distinct	NULL
members	NULL
is	NULL
documented	NULL
and	NULL
may	NULL
allow	NULL
functional	NULL
redundancy	NULL
.	NULL
``	NULL

Another	NULL
Ets	NULL
family	NULL
member	NULL
expressed	NULL
in	NULL
developing	NULL
lymphoid	NULL
cells	NULL
is	NULL
Ets-1	NULL
.	NULL

Ets-l1-deficient	NULL
mice	NULL
demonstrate	NULL
T-cell	NULL
survival	NULL
defects	NULL
,	NULL
accelerated	NULL
terminal	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
and	NULL
reduced	NULL
numbers	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL
``	NULL

We	NULL
found	NULL
that	NULL
PU.1~	NULL
``	NULL
~	NULL
NK	NULL
cells	NULL
express	NULL
higher	NULL
levels	NULL
of	NULL
Ets-1	NULL
transcripts	NULL
,	NULL
and	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
,	NULL
Ets-1	NULL
may	NULL
compensate	NULL
to	NULL
some	NULL
extent	NULL
for	NULL
the	NULL
transcriptional	NULL
regulation	NULL
that	NULL
leads	NULL
to	NULL
NK	NULL
cell	NULL
development	NULL
but	NULL
not	NULL
to	NULL
B-	NULL
and	NULL
T-cell	NULL
development	NULL
.	NULL

However	NULL
,	NULL
a	NULL
functional	NULL
redundancy	NULL
between	NULL
PU.1	NULL
and	NULL
Ets-1	NULL
is	NULL
difficult	NULL
to	NULL
imagine	NULL
,	NULL
as	NULL
these	NULL
2	NULL
members	NULL
share	NULL
only	NULL
40	NULL
%	NULL
homology	NULL
in	NULL
their	NULL
DNA-binding	NULL
domain	NULL
and	NULL
have	NULL
a	NULL
different	NULL
panel	NULL
of	NULL
target	NULL
genes	NULL
.	NULL
``	NULL

Alternatively	NULL
,	NULL
they	NULL
may	NULL
regulate	NULL
nonoverlapping	NULL
functions	NULL
during	NULL
NK	NULL
differentiation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
both	NULL
mice	NULL
and	NULL
PU.1~	NULL
``	NULL
-	NULL
chimeras	NULL
have	NULL
reduced	NULL
numbers	NULL
of	NULL
NK	NULL
cells	NULL
,	NULL
but	NULL
natural	NULL
cytotoxicity	NULL
is	NULL
abolished	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ets-1	NULL
and	NULL
is	NULL
preserved	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PU.1	NULL
.	NULL

Therefore	NULL
,	NULL
PU.1	NULL
deficiency	NULL
is	NULL
compatible	NULL
with	NULL
a	NULL
normal	NULL
differentiation	NULL
of	NULL
the	NULL
lytic	NULL
machinery	NULL
,	NULL
including	NULL
expression	NULL
of	NULL
known	NULL
targets	NULL
of	NULL
Ets	NULL
factors	NULL
such	NULL
as	NULL
LFA-1	NULL
and	NULL
perforin	NULL
,	NULL
'	NULL
``	NULL
whereas	NULL
Ets-1	NULL
may	NULL
be	NULL
essential	NULL
for	NULL
these	NULL
genes	NULL
.	NULL

One	NULL
may	NULL
argue	NULL
that	NULL
the	NULL
NK	NULL
cells	NULL
accumulating	NULL
in	NULL
the	NULL
periphery	NULL
of	NULL
PU.1~	NULL
``	NULL
~-	NULL
chimeras	NULL
may	NULL
have	NULL
undergone	NULL
critical	NULL
alterations	NULL
due	NULL
to	NULL
effects	NULL
of	NULL
the	NULL
mutation	NULL
at	NULL
early	NULL
developmental	NULL
stages	NULL
.	NULL

As	NULL
such	NULL
,	NULL
the	NULL
role	NULL
of	NULL
PU.1	NULL
in	NULL
mature	NULL
NK	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
unambiguously	NULL
assessed	NULL
.	NULL

Conditional	NULL
gene	NULL
targeting	NULL
may	NULL
provide	NULL
a	NULL
solution	NULL
to	NULL
this	NULL
problem	NULL
,	NULL
although	NULL
no	NULL
NK-cell	NULL
lineage-specific	NULL
transgenes	NULL
have	NULL
been	NULL
characterized	NULL
to	NULL
date	NULL
.	NULL

Alternatively	NULL
,	NULL
retroviral-mediated	NULL
transfer	NULL
of	NULL
PU.1*	NULL
``	NULL
into	NULL
mature	NULL
PU.1~	NULL
``	NULL
-	NULL
NK	NULL
cells	NULL
may	NULL
allow	NULL
for	NULL
correction	NULL
of	NULL
their	NULL
phenotypic	NULL
and	NULL
functional	NULL
abnormalities	NULL
.	NULL

Such	NULL
technologic	NULL
improvements	NULL
should	NULL
allow	NULL
for	NULL
a	NULL
finer	NULL
definition	NULL
of	NULL
the	NULL
role	NULL
of	NULL
PU.1	NULL
in	NULL
NK	NULL
cell	NULL
biology	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
there	NULL
is	NULL
a	NULL
less	NULL
restrictive	NULL
requirement	NULL
for	NULL
PU.1	NULL
in	NULL
NK	NULL
cell	NULL
generation	NULL
,	NULL
as	NULL
compared	NULL
to	NULL
myeloid	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Nevertheless	NULL
,	NULL
PU.1	NULL
plays	NULL
critical	NULL
roles	NULL
in	NULL
NK	NULL
cell	NULL
development	NULL
,	NULL
during	NULL
expansion	NULL
of	NULL
committed	NULL
NK	NULL
precursors	NULL
,	NULL
and	NULL
in	NULL
the	NULL
homeostasis	NULL
and	NULL
differentiation	NULL
of	NULL
mature	NULL
NK	NULL
cells	NULL
.	NULL

Acknowledgments	NULL
We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Jean-Christophe	NULL
Bories	NULL
for	NULL
critically	NULL
reading	NULL
the	NULL
manuscript	NULL
;	NULL
Jacques	NULL
Roland	NULL
for	NULL
kindly	NULL
providing	NULL
the	NULL
18.81	NULL
cell	NULL
line	NULL
;	NULL
Eleftheria	NULL
Rosmaraki	NULL
for	NULL
the	NULL
identification	NULL
of	NULL
bone	NULL
marrow	NULL
NK	NULL
cell	NULL
precursors	NULL
;	NULL
and	NULL
Odile	NULL
Richard	NULL
,	NULL
Erwan	NULL
Corcuff	NULL
,	NULL
Géraldine	NULL
Bonnefoy	NULL
,	NULL
and	NULL
Fabien	NULL
Blanchet	NULL
for	NULL
advice	NULL
and	NULL
help	NULL
.	NULL

1	NULL
.	NULL

Trinchieri	NULL
G.	NULL
Biology	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Adv	NULL
5	NULL
.	NULL

2	NULL
.	NULL

Immunol	NULL
.	NULL

1989	NULL
;	NULL
47:187-376	NULL
.	NULL

Ljunggren	NULL
HG	NULL
,	NULL
Karre	NULL
K.	NULL
In	NULL
search	NULL
of	NULL
the	NULL
'missing	NULL
self	NULL
:	NULL
MHC	NULL
molecules	NULL
and	NULL
NK	NULL
cell	NULL
recognition	NULL
.	NULL

Immunol	NULL
Today	NULL
.	NULL

1990	NULL
;	NULL
11:237-244	NULL
.	NULL

Lanier	NULL
LL	NULL
.	NULL

NK	NULL
cell	NULL
receptors	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
.	NULL

1998	NULL
;	NULL
16:359-393	NULL
.	NULL

Kondo	NULL
M	NULL
,	NULL
Weissman	NULL
IL	NULL
,	NULL
Akashi	NULL
K.	NULL
Identification	NULL
of	NULL
clonogenic	NULL
common	NULL
lymphoid	NULL
progenitors	NULL
in	NULL
mouse	NULL
bone	NULL
marrow	NULL
.	NULL

Cell	NULL
.	NULL

1997	NULL
;	NULL
91:661-672	NULL
.	NULL

Rodewald	NULL
HR	NULL
,	NULL
Moingeon	NULL
P	NULL
,	NULL
Lucich	NULL
JL	NULL
,	NULL
Dosiou	NULL
C	NULL
,	NULL
Lopez	NULL
P	NULL
,	NULL
Reinherz	NULL
EL	NULL
.	NULL

A	NULL
population	NULL
of	NULL
early	NULL
fetal	NULL
thymocytes	NULL
expressing	NULL
Fc	NULL
gamma	NULL
RI/I	NULL
!	NULL

!	NULL

contains	NULL
precursors	NULL
of	NULL
T	NULL
lymphocytes	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Cell	NULL
.	NULL

1992	NULL
;	NULL
69:139-150.	NULL
.	NULL

Sanchez	NULL
MJ	NULL
,	NULL
Muench	NULL
MO	NULL
,	NULL
Roncarolo	NULL
MG	NULL
,	NULL
Lanier	NULL
LL	NULL
,	NULL
Phillips	NULL
JH	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
common	NULL
T/natu-	NULL
ral	NULL
killer	NULL
cell	NULL
progenitor	NULL
in	NULL
human	NULL
fetal	NULL
thymus	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1994	NULL
;	NULL
180:569-576	NULL
.	NULL

..	NULL
Kennedy	NULL
MK	NULL
,	NULL
Glaccum	NULL
M	NULL
,	NULL
Brown	NULL
SN	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Re	NULL
versible	NULL
defects	NULL
in	NULL
natural	NULL
killer	NULL
and	NULL
memory	NULL
CD8	NULL
T	NULL
cell	NULL
lineages	NULL
in	NULL
interleukin	NULL
15-deficient	NULL
mice	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

2000	NULL
;	NULL
191:771-780.	NULL
.	NULL

Lodolce	NULL
JP	NULL
,	NULL
Boone	NULL
DL	NULL
,	NULL
Chai	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

IL-15	NULL
recep-	NULL
tor	NULL
maintains	NULL
lymphoid	NULL
homeostasis	NULL
by	NULL
supporting	NULL
lymphocyte	NULL
homing	NULL
and	NULL
proliferation	NULL
.	NULL

Immunity	NULL
.	NULL

1998	NULL
;	NULL
9:669-676.	NULL
.	NULL

Suzuki	NULL
H	NULL
,	NULL
Duncan	NULL
GS	NULL
,	NULL
Takimoto	NULL
H	NULL
,	NULL
Mak	NULL
TW	NULL
.	NULL

Ab	NULL
normal	NULL
development	NULL
of	NULL
intestinal	NULL
intraepithelial	NULL
lymphocytes	NULL
and	NULL
peripheral	NULL
natural	NULL
killer	NULL
cells	NULL
in	NULL
2632	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

COLUCCI	NULL
et	NULL
al	NULL
mice	NULL
lacking	NULL
the	NULL
IL-2	NULL
receptor	NULL
beta	NULL
chain	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1997	NULL
;	NULL
185:499-505	NULL
.	NULL

DiSanto	NULL
JP	NULL
,	NULL
Muller	NULL
W	NULL
,	NULL
Guy-Grand	NULL
D	NULL
,	NULL
Fischer	NULL
A	NULL
,	NULL
Rajewsky	NULL
K.	NULL
Lymphoid	NULL
development	NULL
in	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
deletion	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
gamma	NULL
chain	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1995	NULL
;	NULL
92:377-381	NULL
.	NULL

Park	NULL
SY	NULL
,	NULL
Saijo	NULL
K	NULL
,	NULL
Takahashi	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Developmental	NULL
defects	NULL
of	NULL
lymphoid	NULL
cells	NULL
in	NULL
Jak3	NULL
kinase-defi-cient	NULL
mice	NULL
.	NULL

Immunity	NULL
.	NULL

1995	NULL
;	NULL
3:771-782	NULL
.	NULL

Imada	NULL
K	NULL
,	NULL
Bloom	NULL
ET	NULL
,	NULL
Nakajima	NULL
H	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Statbb	NULL
is	NULL
essential	NULL
for	NULL
natural	NULL
killer	NULL
cell-mediated	NULL
proliferation	NULL
and	NULL
cytolytic	NULL
activity	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1998	NULL
;	NULL
188	NULL
:	NULL
2067-2074	NULL
.	NULL

Williams	NULL
NS	NULL
,	NULL
Klem	NULL
J	NULL
,	NULL
Puzanov	NULL
IJ	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Natural	NULL
killer	NULL
cell	NULL
differentiation	NULL
:	NULL
insights	NULL
from	NULL
knockout	NULL
and	NULL
transgenic	NULL
mouse	NULL
models	NULL
and	NULL
in	NULL
vitro	NULL
sys-tems	NULL
.	NULL

Immunol	NULL
Rev	NULL
.	NULL

1998	NULL
;	NULL
165:47-61	NULL
.	NULL

Glimcher	NULL
LH	NULL
,	NULL
Singh	NULL
H.	NULL
Transcription	NULL
factors	NULL
in	NULL
lymphocyte	NULL
development-T	NULL
and	NULL
B	NULL
cells	NULL
get	NULL
to-gether	NULL
.	NULL

Cell	NULL
.	NULL

1999	NULL
;	NULL
96:13-23	NULL
.	NULL

Ogasawara	NULL
K	NULL
,	NULL
Hida	NULL
S	NULL
,	NULL
Azimi	NULL
N	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Requirement	NULL
for	NULL
IRF-1	NULL
in	NULL
the	NULL
microenvironment	NULL
supporting	NULL
development	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Nature	NULL
.	NULL

1998	NULL
;	NULL
391:700-703	NULL
.	NULL

Kaisho	NULL
T	NULL
,	NULL
Tsutsui	NULL
H	NULL
,	NULL
Tanaka	NULL
T	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Impairment	NULL
of	NULL
natural	NULL
killer	NULL
cytotoxic	NULL
activity	NULL
and	NULL
interferon	NULL
gamma	NULL
production	NULL
in	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
gamma-deficient	NULL
mice	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1999	NULL
;	NULL
190:1573-1582	NULL
.	NULL

Yokota	NULL
Y	NULL
,	NULL
Mansouri	NULL
A	NULL
,	NULL
Mori	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Development	NULL
of	NULL
peripheral	NULL
lymphoid	NULL
organs	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
depends	NULL
on	NULL
the	NULL
helix-loop-helix	NULL
inhibitor	NULL
Id2	NULL
.	NULL

Nature	NULL
.	NULL

1999	NULL
;	NULL
397:702-706	NULL
.	NULL

Bassuk	NULL
AG	NULL
,	NULL
Leiden	NULL
JM	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
development	NULL
and	NULL
function	NULL
of	NULL
the	NULL
mammalian	NULL
immune	NULL
system	NULL
.	NULL

Adv	NULL
Immunol	NULL
.	NULL

1997	NULL
;	NULL
64:65-104	NULL
.	NULL

Scott	NULL
EW	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Anastasi	NULL
J	NULL
,	NULL
Singh	NULL
H.	NULL
Requirement	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
development	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Science	NULL
.	NULL

1994	NULL
;	NULL
265:1573-1577	NULL
.	NULL

McKercher	NULL
SR	NULL
,	NULL
Torbett	NULL
BE	NULL
,	NULL
Anderson	NULL
KL	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
PU.1	NULL
gene	NULL
results	NULL
in	NULL
multiple	NULL
hematopoietic	NULL
abnormalities	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1996	NULL
;	NULL
15:5647-5658	NULL
.	NULL

Spain	NULL
LM	NULL
,	NULL
Guerriero	NULL
A	NULL
,	NULL
Kunjibettu	NULL
S	NULL
,	NULL
Scott	NULL
EW	NULL
.	NULL

T	NULL
cell	NULL
development	NULL
in	NULL
PU.1	NULL
-deficient	NULL
mice	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1999	NULL
;	NULL
163:2681-2687	NULL
.	NULL

Colucci	NULL
F	NULL
,	NULL
Soudais	NULL
C	NULL
,	NULL
Rosmaraki	NULL
E	NULL
,	NULL
Vanes	NULL
L	NULL
,	NULL
Ty-bulewicz	NULL
VL	NULL
,	NULL
Di	NULL
Santo	NULL
JP	NULL
.	NULL

Dissecting	NULL
NK	NULL
cell	NULL
development	NULL
using	NULL
a	NULL
novel	NULL
alymphoid	NULL
mouse	NULL
model	NULL
:	NULL
investigating	NULL
the	NULL
role	NULL
of	NULL
the	NULL
c-abl	NULL
proto-oncogene	NULL
in	NULL
murine	NULL
NK	NULL
cell	NULL
differentiation	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1999	NULL
;	NULL
162:2761-2765	NULL
.	NULL

Colucci	NULL
F	NULL
,	NULL
Di	NULL
Santo	NULL
JP	NULL
.	NULL

The	NULL
receptor	NULL
tyrosine	NULL
c-kit	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

286	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36.	NULL
provides	NULL
a	NULL
critical	NULL
signal	NULL
for	NULL
survival	NULL
,	NULL
expansion	NULL
,	NULL
and	NULL
maturation	NULL
of	NULL
mouse	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:984-991	NULL
.	NULL

Colucci	NULL
F	NULL
,	NULL
Turner	NULL
M	NULL
,	NULL
Schweighoffer	NULL
E	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Redundant	NULL
role	NULL
of	NULL
the	NULL
syk	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
in	NULL
mouse	NULL
NK	NULL
cell	NULL
differentiation	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

1999	NULL
;	NULL
163:1769-1774	NULL
.	NULL

Scott	NULL
EW	NULL
,	NULL
Fisher	NULL
RC	NULL
,	NULL
Olson	NULL
MC	NULL
,	NULL
Kehrli	NULL
EW	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Singh	NULL
H.	NULL
PU.1	NULL
functions	NULL
in	NULL
a	NULL
cell-autonomous	NULL
manner	NULL
to	NULL
control	NULL
the	NULL
differentiation	NULL
of	NULL
multipotential	NULL
lymphoid-myeloid	NULL
progenitors	NULL
.	NULL

Immunity	NULL
.	NULL

1997	NULL
;	NULL
6:437-447	NULL
.	NULL

Akashi	NULL
K	NULL
,	NULL
Traver	NULL
D	NULL
,	NULL
Miyamoto	NULL
T	NULL
,	NULL
Weissman	NULL
IL	NULL
.	NULL

A	NULL
clonogenic	NULL
common	NULL
myeloid	NULL
progenitor	NULL
that	NULL
gives	NULL
rise	NULL
to	NULL
all	NULL
myeloid	NULL
lineages	NULL
.	NULL

Nature	NULL
.	NULL

2000	NULL
;	NULL
404	NULL
:	NULL
193-197	NULL
.	NULL

Anderson	NULL
MK	NULL
,	NULL
Hernandez-Hoyos	NULL
G	NULL
,	NULL
Diamond	NULL
RA	NULL
,	NULL
Rothenberg	NULL
EV	NULL
.	NULL

Precise	NULL
developmental	NULL
regulation	NULL
of	NULL
Ets	NULL
family	NULL
transcription	NULL
factors	NULL
during	NULL
specification	NULL
and	NULL
commitment	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
lin-eage	NULL
.	NULL

Development	NULL
.	NULL

1999	NULL
;	NULL
126:3131-3148	NULL
.	NULL

Guerriero	NULL
A	NULL
,	NULL
Langmuir	NULL
PB	NULL
,	NULL
Spain	NULL
LM	NULL
,	NULL
Scott	NULL
EW	NULL
.	NULL

PU.1	NULL
is	NULL
required	NULL
for	NULL
myeloid-derived	NULL
but	NULL
not	NULL
lymphoid-derived	NULL
dendritic	NULL
cells	NULL
.	NULL

Blood	NULL
.	NULL

2000	NULL
;	NULL
95:879-885	NULL
.	NULL

Fisher	NULL
RC	NULL
,	NULL
Lovelock	NULL
JD	NULL
,	NULL
Scott	NULL
EW	NULL
.	NULL

A	NULL
critical	NULL
role	NULL
for	NULL
PU.1	NULL
in	NULL
homing	NULL
and	NULL
long-term	NULL
engraftment	NULL
by	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
.	NULL

Blood	NULL
.	NULL

1999	NULL
;	NULL
94:1283-1290	NULL
.	NULL

Barton	NULL
K	NULL
,	NULL
Muthusamy	NULL
N	NULL
,	NULL
Fischer	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

The	NULL
Ets-1	NULL
transcription	NULL
factor	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
in	NULL
mice	NULL
.	NULL

Immunity	NULL
.	NULL

1998	NULL
;	NULL
9:555-563	NULL
.	NULL

Shelley	NULL
CS	NULL
,	NULL
Farokhzad	NULL
OC	NULL
,	NULL
Arnaout	NULL
MA	NULL
.	NULL

Identification	NULL
of	NULL
cell-specific	NULL
and	NULL
developmentally	NULL
regulated	NULL
nuclear	NULL
factors	NULL
that	NULL
direct	NULL
myeloid	NULL
and	NULL
lymphoid	NULL
expression	NULL
of	NULL
the	NULL
CD11a	NULL
gene	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
U	NULL
S	NULL
A	NULL
.	NULL

1993	NULL
;	NULL
90:5364-5368	NULL
.	NULL

Rosmarin	NULL
AG	NULL
,	NULL
Caprio	NULL
DG	NULL
,	NULL
Kirsch	NULL
DG	NULL
,	NULL
Handa	NULL
H	NULL
,	NULL
Simkevich	NULL
CP	NULL
.	NULL

GABP	NULL
and	NULL
PU.1	NULL
compete	NULL
for	NULL
bind-ing	NULL
,	NULL
yet	NULL
cooperate	NULL
to	NULL
increase	NULL
CD18	NULL
(	NULL
beta	NULL
2	NULL
leukocyte	NULL
integrin	NULL
)	NULL
transcription	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

1995	NULL
;	NULL
270:23627-23633	NULL
.	NULL

Raulet	NULL
DH	NULL
.	NULL

Development	NULL
and	NULL
tolerance	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
.	NULL

1999	NULL
;	NULL
11:129-134	NULL
.	NULL

Held	NULL
W	NULL
,	NULL
Kunz	NULL
B	NULL
,	NULL
Lowin-Kropf	NULL
B	NULL
,	NULL
van	NULL
de	NULL
Wetering	NULL
M	NULL
,	NULL
Clevers	NULL
H.	NULL
Clonal	NULL
acquisition	NULL
of	NULL
the	NULL
Ly49A	NULL
NK	NULL
cell	NULL
receptor	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
trans-acting	NULL
factor	NULL
TCF-1	NULL
.	NULL

Immunity	NULL
.	NULL

1999	NULL
;	NULL
11:433-442	NULL
.	NULL

Lloberas	NULL
J	NULL
,	NULL
Soler	NULL
C	NULL
,	NULL
Celada	NULL
A	NULL
.	NULL

The	NULL
key	NULL
role	NULL
of	NULL
PU.1/SPI-1	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
myeloid	NULL
cells	NULL
and	NULL
macro-phages	NULL
.	NULL

Immunol	NULL
Today	NULL
.	NULL

1999	NULL
;	NULL
20:184-189	NULL
.	NULL

Mazurier	NULL
F	NULL
,	NULL
Fontanellas	NULL
A	NULL
,	NULL
Salesse	NULL
S	NULL
,	NULL
et	NULL
al	NULL
.	NULL

A	NULL
novel	NULL
immunodeficient	NULL
mouse	NULL
model-RAG2	NULL
x	NULL
common	NULL
cytokine	NULL
receptor	NULL
gamma	NULL
chain	NULL
double	NULL
mutants-requiring	NULL
exogenous	NULL
cytokine	NULL
adminis-	NULL
BLOOD	NULL
,	NULL
1	NULL
MAY	NULL
2001	NULL
«	NULL
VOLUME	NULL
97	NULL
,	NULL
NUMBER	NULL
9	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49.	NULL
tration	NULL
for	NULL
human	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
engraft-ment	NULL
.	NULL

J	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

1999	NULL
;	NULL
19:533-541	NULL
.	NULL

DeKoter	NULL
RP	NULL
,	NULL
Walsh	NULL
,	NULL
JC	NULL
,	NULL
Singh	NULL
H.	NULL
PU.1	NULL
regulates	NULL
both	NULL
cytokine-dependent	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
granulocyte/macrophage	NULL
progenitors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

1998	NULL
;	NULL
17:4456-4468	NULL
.	NULL

Anderson	NULL
KL	NULL
,	NULL
Smith	NULL
KA	NULL
,	NULL
Pio	NULL
F	NULL
,	NULL
Torbeit	NULL
BE	NULL
,	NULL
Maki	NULL
RA	NULL
.	NULL

Neutrophils	NULL
deficient	NULL
in	NULL
PU.1	NULL
do	NULL
not	NULL
terminally	NULL
differentiate	NULL
or	NULL
become	NULL
functionally	NULL
compe-tent	NULL
.	NULL

Blood	NULL
.	NULL

1998	NULL
;	NULL
92:1576-1585	NULL
.	NULL

Anderson	NULL
KL	NULL
,	NULL
Perkin	NULL
H	NULL
,	NULL
Surh	NULL
CD	NULL
,	NULL
Venturini	NULL
S	NULL
,	NULL
Maki	NULL
RA	NULL
,	NULL
Torbeit	NULL
BE	NULL
.	NULL

Transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
necessary	NULL
for	NULL
development	NULL
of	NULL
thymic	NULL
and	NULL
myeloid	NULL
progenitor-derived	NULL
dendritic	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

2000	NULL
;	NULL
164:1855-1861	NULL
.	NULL

Singh	NULL
H	NULL
,	NULL
DeKoter	NULL
RP	NULL
,	NULL
Walsh	NULL
JC	NULL
.	NULL

PU.1	NULL
,	NULL
a	NULL
shared	NULL
transcriptional	NULL
regulator	NULL
of	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cell	NULL
fates	NULL
.	NULL

Cold	NULL
Spring	NULL
Harb	NULL
Symp	NULL
Quant	NULL
Biol	NULL
.	NULL

1999	NULL
;	NULL
64:13-30	NULL
.	NULL

Pongubala	NULL
JM	NULL
,	NULL
Nagulapalli	NULL
S	NULL
,	NULL
Klemsz	NULL
MJ	NULL
,	NULL
McKercher	NULL
SR	NULL
,	NULL
Maki	NULL
RA	NULL
,	NULL
Atchison	NULL
ML	NULL
.	NULL

PU.1	NULL
recruits	NULL
a	NULL
second	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
site	NULL
important	NULL
for	NULL
immunoglobulin	NULL
kappa	NULL
3	NULL
'	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1992	NULL
;	NULL
12:368-378	NULL
.	NULL

Nelsen	NULL
B	NULL
,	NULL
Tian	NULL
G	NULL
,	NULL
Erman	NULL
B	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Regulation	NULL
of	NULL
lymphoid-specific	NULL
immunoglobulin	NULL
mu	NULL
heavy	NULL
chain	NULL
gene	NULL
enhancer	NULL
by	NULL
ETS-domain	NULL
proteins	NULL
.	NULL

Science	NULL
.	NULL

1993	NULL
;	NULL
261:82-86	NULL
.	NULL

Eisenbeis	NULL
CF	NULL
,	NULL
Singh	NULL
H	NULL
,	NULL
Storb	NULL
U.	NULL
PU.1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
multiprotein	NULL
complex	NULL
which	NULL
binds	NULL
an	NULL
essential	NULL
site	NULL
in	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
lambda	NULL
2-4	NULL
enhancer	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

1993	NULL
;	NULL
13	NULL
:	NULL
6452-6461	NULL
.	NULL

DeKoter	NULL
RP	NULL
,	NULL
Singh	NULL
H.	NULL
Regulation	NULL
of	NULL
B	NULL
lymphocyte	NULL
and	NULL
macrophage	NULL
development	NULL
by	NULL
graded	NULL
expression	NULL
of	NULL
PU.1	NULL
.	NULL

Science	NULL
.	NULL

2000	NULL
;	NULL
288:1439-1441	NULL
.	NULL

Carlyle	NULL
JR	NULL
,	NULL
Michie	NULL
AM	NULL
,	NULL
Furlonger	NULL
C	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
developmental	NULL
stage	NULL
marking	NULL
lineage	NULL
commitment	NULL
of	NULL
progenitor	NULL
thymocytes	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

1997	NULL
;	NULL
186:173-182	NULL
.	NULL

Di	NULL
Santo	NULL
JP	NULL
,	NULL
Rodewald	NULL
HR	NULL
.	NULL

In	NULL
vivo	NULL
roles	NULL
of	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
and	NULL
cytokine	NULL
receptors	NULL
in	NULL
early	NULL
thymocyte	NULL
development	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
.	NULL

1998	NULL
;	NULL
10:196-207	NULL
.	NULL

Brown	NULL
MG	NULL
,	NULL
Scalzo	NULL
AA	NULL
,	NULL
Matsumoto	NULL
K	NULL
,	NULL
Yokoyama	NULL
WM	NULL
.	NULL

The	NULL
natural	NULL
killer	NULL
gene	NULL
complex	NULL
:	NULL
a	NULL
genetic	NULL
basis	NULL
for	NULL
understanding	NULL
natural	NULL
killer	NULL
cell	NULL
function	NULL
and	NULL
innate	NULL
immunity	NULL
.	NULL

Immunol	NULL
Rev	NULL
.	NULL

1997	NULL
;	NULL
155:53-65	NULL
.	NULL

Bories	NULL
JC	NULL
,	NULL
Willerford	NULL
DM	NULL
,	NULL
Grevin	NULL
D	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Increased	NULL
T-cell	NULL
apoptosis	NULL
and	NULL
terminal	NULL
B-cell	NULL
differentiation	NULL
induced	NULL
by	NULL
inactivation	NULL
of	NULL
the	NULL
Ets-1	NULL
proto-oncogene	NULL
.	NULL

Nature	NULL
.	NULL

1995	NULL
;	NULL
377:635-638	NULL
.	NULL

Muthusamy	NULL
N	NULL
,	NULL
Barton	NULL
K	NULL
,	NULL
Leiden	NULL
JM	NULL
.	NULL

Defective	NULL
activation	NULL
and	NULL
survival	NULL
of	NULL
T	NULL
cells	NULL
lacking	NULL
the	NULL
Ets-1	NULL
transcription	NULL
factor	NULL
.	NULL

Nature	NULL
.	NULL

1995	NULL
;	NULL
377:639-642	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
2001	NULL
97	NULL
:	NULL
2625-2632	NULL
doi:10.1182/blood.V97.9.2625	NULL
Differential	NULL
requirement	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
versus	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
TY	NULL
O	NULL
0C	NULL
,	NULL
A	NULL
f	NULL
gm	NULL
“	NULL
CA	NULL
N	NULL
,	NULL
6	NULL
'	NULL
*	NULL
f	NULL
)	NULL
..	NULL

I	NULL
f	NULL
2	NULL
``	NULL
O10	NULL
(	NULL
@	NULL
0	NULL
Francesco	NULL
Colucci	NULL
,	NULL
Sandrine	NULL
I.	NULL
Samson	NULL
,	NULL
Rodney	NULL
P.	NULL
DeKoter	NULL
,	NULL
Olivier	NULL
Lantz	NULL
,	NULL
Harinder	NULL
Singh	NULL
and	NULL
James	NULL
P.	NULL
Di	NULL
Santo	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/97/9/2625.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Gene	NULL
Expression	NULL
(	NULL
1086	NULL
articles	NULL
)	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Immunobiology	NULL
and	NULL
Immunotherapy	NULL
(	NULL
5679	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

